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ABSTRACT

Cryptosporidium species are eukaryotic intracellular parasites belonging to the
phylum Apicomplexa. C. hominis and C. parvum cause diarrhea in humans which is
self-limiting in immunocompetent adults but can have severe consequences in
immunocompromised individuals and malnourished children. In developing countries,
Cryptosporidium is one of the leading causes of moderate to severe diarrhea in children
under five years of age. There is an urgent need for novel therapeutics against this
parasite as the current treatment option is inadequate to treat the most vulnerable
population to Cryptosporidium infection. Better understandings of the biology of
Cryptosporidium would greatly enhance our capability to design effective control
measures.
The parasite initially multiplies through several rounds of asexual replication
within the intestinal epithelial cells before differentiating into sexual forms. Here we
have tested the ReFRAME library, a set of ~12,000 biologically active compounds, for
activities against the asexual and sexual forms of C. parvum separately. We identified
and validated compounds that inhibit and/or induce the growth of either or both life
cycle stages. Compounds that inhibit both stages are potentially good drug candidates.
Other compounds have promising tool-like properties that can be utilized to probe
different aspects of C. parvum sexual differentiation. Several inhibitors of host cell
oxidative phosphorylation and purine nucleotide biosynthesis disproportionately
inhibited the sexual differentiation of C. parvum, highlighting the necessity of these
processes in facilitating C. parvum sexual differentiation.
All the apicomplexan parasites differentiate into distinct forms in the course of
their life cycle and each of the differentiation steps is associated with large scale
changes in gene expression. To identify such stage specific genes and pathways
associated with C. parvum sexual differentiation, we performed mRNA-seq of host
cells infected with C. parvum in the presence of nine differentiation inhibitors.
Ribosomal proteins were the most significantly enriched group of genes that were
upregulated with multiple differentiation inhibitors, which suggested that the
downregulation of these genes is associated with C. parvum sexual differentiation.
Comparison of our results with a publicly available stage-specific mRNA-seq dataset of
C. parvum validated this conclusion and analysis of transcriptomic datasets from other
apicomplexan parasites revealed that this is a common mechanism of regulating life
cycle stage differentiation in these parasites. In addition, identification of significantly
enriched DNA motifs at promoters of dysregulated genes coupled with the expression
pattern of several apicomplexan AP2 transcription factors strongly suggested that they
play a critical role in regulating C. parvum sexual differentiation.
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CHAPTER 1: A REVIEW OF THE MECHANISMS THAT REGULATE
STAGE DIFFERENTIATION DURING THE LIFE CYCLE PROGRESSION
OF APICOMPLEXAN PARASITES

1.1: Purpose of this Review
The major goal of this thesis was to identify mechanisms underlying
differentiation of the apicomplexan parasite Cryptosporidium.

For this, we relied

heavily on the main strengths of our laboratory, which are in the areas of high
throughput assay development and drug screening. We describe development of a
microscopy-based screening assay for asexual to sexual stage development of
Cryptosporidium, its use to screen a library of biologically active small molecules, and
then follow up studies to characterize the effects of identified inhibitors using RNAseq.

This literature review chapter provides background on parasites related to

Cryptosporidium within the phylum Apicomplexa, what is known about differentiation
of major apicomplexan parasites, and general themes that have emerged from prior
research on apicomplexan differentiation.

1.2: Origin and Classification of Apicomplexan Parasites
Apicomplexa is a phylum of unicellular eukaryotes that are obligate
intracellular parasites. The defining characteristic of this phylum is that they all harbor
an apical complex, a structure composed of specialized organelles and cytoskeletal
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structures, during at least one stage of their life cycle. It is present at the anterior end of
the parasite and is required to invade the host cell. Apicomplexans infect almost all
vertebrates and invertebrates and the host specificity of each species is relatively
restricted, with some notable exceptions (1-3).
Another feature of apicomplexans beside the apical complex is the apicoplast, a
non-photosynthetic plastid, that is present in most of the apicomplexan parasites. The
apicoplast genome has given us major clues about the origin and evolution of
apicomplexans. The four membrane enclosure of the apicoplast suggests a secondary
endosymbiotic origin of the organelle (4).

Such an organelle is, however, not

completely unique in apicomplexans. Around half of the members of Dinoflagellata, a
sister phylum of Apicomplexa consisting of unicellular planktons, are among the other
groups of organisms that contain a secondary endosymbiotic plastid (4). Interestingly,
even though phylogenetic analysis of plastid rRNAs shows that apicomplexan and
dinoflagellate plastids came from the same origin, their gene sets do not overlap a lot
(5). Discovery of the unicellular photosynthetic organisms Chromera velia and Vitrella
brassicaformis provided the missing link between apicomplexans and dinoflagellates
(6, 7). Both of them have a secondary endosymbiotic plastid that encode a superset of
genes present in the plastids of apicomplexans and dinoflagellates.

Phylogenetic

analysis of their plastid genome reinforced the already widely supported notion that
their plastid, just like the plastids of apicomplexans and dinoflagellates, originated from
red algal plastids (6). Phylogenetic trees constructed using the 18S rRNA and nuclear
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genes also point towards a common ancestor of apicomplexans, dinoflagellates and
chrompodellids (Chromera velia, Vitrella brassicaformis, and other related genera) (8,
9). Therefore, the currently held view is that the common ancestor of all three above
mentioned groups was a free-living photosynthetic unicellular eukaryote with a
secondary endosymbiotic plastid of red algal origin. Subsequent evolution of this
ancestor gave rise to several lines, some keeping the photosynthetic capability while
apicomplexans lost it (10, 11). Importantly, there are groups of organisms in different
lineages originating from this ancestor that have also completely lost the plastid (9).
Transfer of genes between organelle genome and nuclear genome, termed
endosymbiotic gene transfer, is very common in eukaryotes, including apicomplexans
(12, 13). A class of transcription factors (TFs), the Apetala 2 (AP2) domain-containing
TFs, exemplify such a mode of gene transfer between apicoplast and nuclear genome.
Several apicomplexans severely lack common TF families normally present in animal
cells (14). In silico identification of DNA binding proteins followed by searching their
homologs in all life forms identified that several apicomplexan DNA binding proteins
share homology to plant Apetala 2 domain-containing transcription factors (14). The
apicomplexan orthologues are named Apicomplexan AP2 (ApiAP2) TFs. Genomes of
all apicomplexans, as well as their apicoplast bearing cousins sequenced so far, have
this family of TFs in their genome, some more than the others (14, 15). This suggests
that after an initial endosymbiotic transfer, this family of TFs later expanded in a
lineage-specific manner (14).

The role of ApiAP2 TFs in apicomplexan gene
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regulation has been studied extensively and several of them play key regulatory roles in
the progression of the apicomplexan life cycle.
Apicomplexans can be broadly divided into four different groups based on
phylogenetic analyses, structural features and host range (1, 2, 16, 17). The most
understudied among them are the gregarines, which are parasites of invertebrates.
Advances in environmental DNA sequencing are slowly unearthing an abundance of
gregarine parasites in diverse environments; however, molecular characterization of the
members of this group is scarce (8, 18, 19). Phylogenetically, gregarines are difficult
to group together among themselves, leading to them being called deep-branching
apicomplexans (8, 9). The apicoplast is presumed to be lost in many gregarines (9).
Members of the sole genus Cryptosporidium constitutes the second major group of
apicomplexans. These are parasites of the vertebrate gastrointestinal tract. None of the
Cryptosporidium species harbors an apicoplast and they have also lost a fully functional
mitochondrion. Instead, they have a mitochondrion-like organelle called a mitosome
that lacks its own genome. Several nuclear-encoded genes are nonetheless targeted to
this relict mitochondrion and its primary function seems to be Fe-S cluster generation
(20-22). Until recently, Cryptosporidium species were considered to be members of
another major apicomplexan group called the coccidians (17). Coccidians are parasites
of both vertebrates and invertebrates. Their similarity to Cryptosporidium is that they
produce cysts that are the infective form of the parasite.

However, unlike

Cryptosporidium, they have functional apicoplasts and mitochondria. Coccidians are
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very diverse in their host range; some of them are specific for certain host species,
while others have a broader host range (23, 24). The most well-studied coccidian
parasite is Toxoplasma gondii, which is often used as a model apicomplexan due to the
availability of well-established genetic manipulation systems for this parasite. Finally,
the other group of apicomplexans, haematozoa, are parasites of the vertebrate
circulatory system that are transmitted by blood-sucking insect vectors. The insect
vectors are the definitive hosts of this group of parasites, as sexual replication occurs
within them, while vertebrates are intermediate hosts where they replicate asexually.
The apical complex of haematozoans lacks a conoid, a special arrangement of
microtubules, that is present in the apical complex of all the other groups of
apicomplexan parasites (25, 26).

Plasmodium parasites, the causative agents of

malaria, belong to this group.

1.3: Significance of the Research on Apicomplexan Stage Differentiation and
Scope of this Review
One of the common aspects of the life cycle of all the apicomplexan parasites is
that they differentiate into distinct forms at various stages of their life cycle. All of
them have at least three different forms, namely, sporozoites, asexual replicative forms,
and sexual replicative forms. The term for asexual replicative forms varies by species.
There is no sex chromosome in apicomplexans, but mature gametes are dimorphic.
Most commonly, one gamete is comparatively larger than the other gamete, which is
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called the macrogamete or the female gamete. The comparatively smaller gamete,
which is usually formed from a gametocyte containing multiples of them, is called the
microgamete or male gamete. A gamete within a host cell is called a gametocyte.
Additionally, based on the species, they take other special forms through the
progression of their life cycle.
Apicomplexan differentiation has been an active area of research. The fact that
each of these unicellular intracellular parasites can transform into very different forms
characterized by altered structures and phenotypic characteristics, as well as different
modes of replication and metabolism, while maintaining essentially the same genetic
makeup makes apicomplexan parasites ideal candidates to study the regulation of gene
expression and basic cell biology. From an evolutionary and ecological perspective,
how apicomplexans survive in diverse conditions and each establishes its own
ecological niche are of huge interest.
Several apicomplexans cause significant diseases in humans that are of major
public health and economic concern. Plasmodium parasites cause malaria, which still
kills thousands of people every year. Blocking Plasmodium differentiation in people is
central to transmission-blocking strategies (27). Around one third of the population in
the world are thought to be chronically infected with T. gondii gondii, an opportunistic
pathogen of humans. The secret behind this astonishingly high prevalence is its ability
to differentiate into a cyst form, which is untreatable with the current therapeutics (28).
Cryptosporidium has recently been identified as one of the major causes of childhood
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diarrhea in the developing world (29). There is no efficacious therapeutic available for
Cryptosporidium infection of immunocompromised patients and malnourished
children, the two most vulnerable populations to Cryptosporidium infection (30). Our
current

understanding

of

Cryptosporidium

biology

suggests

that

blocking

differentiation would be an effective therapeutic strategy against this parasite.
Early development of apicomplexan parasites within the human body involves
differentiation from the environmentally resistant form or vector transmissive form to a
more human adopted form capable of establishing an infection. Each of the pathogenic
Apicomplexa subsequently differentiate further to rapidly replicating forms that are
more associated with the pathologies of the diseases they cause. While inhibiting the
later stages are straightforward strategies in drug development, understanding the early
stages are more important towards vaccine development. Development of attenuated
strains incapable of early differentiation as well as using early stage-specific cell
surface markers as subunit vaccines are two of the most common strategies employed
in anti-apicomplexan vaccine development (31, 32).
Unsurprisingly, detailed studies on the molecular mechanism of differentiation
have been mainly performed on apicomplexan genera that are pathogens of human or
economically important pathogens of livestock and poultry. In this review, we will
discuss the differentiation of three haematozoans (Plasmodium, Babesia, Theileria),
two coccidians (T. gondii and Eimeria) and the sole genus of the group
Cryptosporidium. Notable pathogens that are not discussed due to relative scarcity of
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differentiation-related literature include two coccidian parasites, the human pathogen
Cyclospora and the livestock pathogen Neospora. No gregarine parasite has been
discussed, as their molecular mechanism of differentiation has not been studied yet
(33).
A key aspect of the apicomplexan differentiation processes is the extensive
change in the global gene expression pattern associated with differentiation. Emphasis
has been given in this review about characterizing these global changes, as well as key
components that play master regulatory roles in bringing about these changes.
However, numerous studies have also been performed to understand the structures and
functions of components that have roles in the developmental progression of each of
the distinct differentiated stages. Several comprehensive reviews have been published
discussing such components for a particular stage of each of the parasites’ life cycles.
Instead of repeating the same information in this review, we have referred to those
articles wherever appropriate.

1.4: Plasmodium Stage Differentiation
Plasmodium parasites are the causative agents of malaria, which killed more
than 400 thousand people in 2018.

Vertebrates are the intermediate hosts and

mosquitos are the definitive hosts of Plasmodium species. Six Plasmodium species
infect humans, among them P. falciparum is the most well-studied species. Several
simian, avian and rodent Plasmodium species are used as model organisms in
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laboratory settings to understand its biology (34). Notable among them are the rodent
parasites P. berghei and P. yoelii. Continuous in vitro cultivation of several species of
Plasmodium is performed within red blood cells (RBCs) (35).
1.4.1: Sporozoite to Liver Stage Differentiation
Sporozoites, the form of Plasmodium parasites that initiates infection of the
vertebrate host, encounter the most diverse conditions among all the life cycle stages of
Plasmodium (Figure 1). They are developed inside oocysts residing at basal lamina of
the mosquito midgut, and after egressing from the oocyst, they travel via hemolymph to
the mosquito salivary gland and invade it. Salivary gland sporozoites are inoculated
into vertebrate skin during a mosquito bite, traverse the dermis to gain entry into the
blood circulation, and then, in mammalian hosts, sporozoites again traverse the
endothelial cells in liver sinusoids to access hepatocytes where they can start the
exoerythrocytic phase of the infection (36, 37). It is not surprising that sporozoites at
different stages of this process differ from each other. Many Plasmodium genes have
been identified that are essential for a specific part of the sporozoite’s life while
dispensable for the others. It suggests a model of stepwise maturation of sporozoites
capable of establishing infection in the liver (36, 37).
Interestingly, commitment to the exoerythrocytic phase seems to be attained
even before the sporozoites contact the vertebrate host. First shown in the rodent
parasite Plasmodium berghei, sporozoites from the salivary gland are 10,000 times
more infectious to the mammalian host than sporozoites from oocysts (38). The same
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phenomenon was subsequently shown in several other Plasmodium species, and, with
the avian parasite P. gallenaceum, it was shown that salivary gland sporozoites lose
infectivity for the mosquito salivary gland once they were reintroduced into the
mosquito hemocoel (39). Sporozoites in the hemolymph show intermediate infectivity
and other intermediate phenotypic characteristics that fall between the characteristics of
salivary gland sporozoites and oocyst sporozoites (40).
Comparative transcriptomics and proteomics analyses between oocyst
sporozoites and salivary gland sporozoites to determine the regulation of this
commitment have identified multiple genes upregulated in one population compared to
others (41-44). Knockout of several of the genes upregulated in infectious sporozoites
(UIS) formed parasites that are capable of infecting hepatocytes, but then fail to
successfully replicate inside them (45-49). The most studied among them, which has
often been used as a marker for salivary gland oocyst and liver stage Plasmodium, is
UIS4 (45). UIS4 regulation in sporozoites and liver stage Plasmodium provides
important mechanistic details about Plasmodium sporozoite to

liver stage

differentiation (45). Even though UIS4 mRNA is highly expressed in salivary gland
sporozoites, it is post-transcriptionally repressed in sporozoites and the protein level
eventually goes up in the liver stage (50). The RNA binding protein Puf2 binds to the
UIS4 transcript and keeps it in a repressed state (51). Puf2 knockout sporozoites reach
the salivary gland, but cannot infect the liver (47, 48, 52).

This mutant also

differentiates into a form that resembles early liver stage Plasmodium while still
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residing in the mosquito salivary gland (47, 48, 52).
Several studies suggest that this transcriptionally active but translationally
repressed state is not a unique feature of UIS4, and that this is a general strategy of
Plasmodium to be prepared for infection upon switching hosts (44, 48, 53, 54). Indeed,
the kinase IK2 that phosphorylates and inactivates translation initiation factor eIF2α has
been shown to be an important regulator of this process in Plasmodium (54). IK2
knockout parasites showed reduced phosphorylation of eIF2α and an overall
upregulated protein translation, including translation of UIS4, in sporozoites (54).
Phenotypically, the IK2 knockout mutant also prematurely develops into a liver stage
like form (54). Translationally repressed UIS mRNAs, including UIS4, are actively
protected from degradation in salivary gland sporozoites, and a Plasmodium protein
called SAP is involved in that process (49). Like the other mutants mentioned before,
SAP knockout also inhibits liver stage development (49).
Recently, RNA-seq based transcriptomics, quantitative proteomics, and high
throughput screening of knockout mutant libraries have verified some of those earlier
findings, while also generating a clearer landscape of metabolic changes during
differentiation (55-58).

For example, a mutant library screening demonstrated

essentiality of the type II fatty acid biosynthetic pathway in liver stage development
(58).

Some of the members in this pathway are upregulated in salivary gland

sporozoites, and were previously shown to be essential in parasite development into the
liver stage (59, 60). Another study performed comparative RNA-seq and proteomics
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analyses of oocyst sporozoites and salivary gland sporozoites of both P. yoelii and P.
falciparum, and validated the translational repression program in salivary gland
sporozoites (57). Interestingly, this study also suggests an independent translational
repression program in oocyst sporozoites that is released after sporozoite invasion of
the salivary gland (57). This might be the explanation for the inability of salivary gland
sporozoites to reinfect the salivary gland as mentioned before (39). Follow up genetic
experiments based on these high throughput sequencing analyses (57) would likely help
in identifying genes and pathways critical for differentiation.
The stimulus for sporozoite to liver stage differentiation has been suggested to
be dependent on time (i.e. after a certain time, a sporozoite is committed to
differentiation) and space (i.e. the environment around a sporozoite determines its stage
of commitment); however, no definite molecular signal has been established yet. In
terms of a transcriptional regulator, AP2-L is an AP2 transcription factor that is
necessary for liver-stage development (61-63). AP2-L protein is expressed in blood
stage, sporozoite and liver-stage P. berghei, but the AP2-L knockout mutant showed
complete developmental arrest only in Liver stage (61). Knockout mutants of three
other AP2 TFs in P. berghei failed to form sporozoites from oocysts, or the sporozoites
failed to reach the salivary gland (62-64). Detailed identification and characterization
of the targets of these transcription factors would likely provide more information about
the differentiation of sporozoites.
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1.4.2: Liver Stage to Erythrocytic Stage Differentiation
The exoerythrocytic cycle for mammalian Plasmodium species takes place
within hepatic cells (Figure 1). A sporozoite first transforms into a trophozoite, which
then replicates into thousands of merozoites within a single hepatic cell. Packets of
merozoites called merosomes bud out from the hepatic cells into the blood, and are
ultimately released to start the erythrocytic cycle of Plasmodium infection (65, 66).
Numerous individual proteins are implicated at different stages of this development
process through single-gene knockout studies (nicely summarized in Table 1 of (67)).
However, identification of master regulatory elements involved in exoerythrocytic to
erythrocytic stage differentiation is still absent. One potential reason for this is the
scarcity of transcriptomic and proteomics data in high enough temporal or phenotypic
resolution as to differentiate different stages of the exoerythrocytic phase. Fortunately,
such experiments are starting to come out (55, 56). Another reason that is likely
hampering the characterization of master regulatory elements is the standard genetic
manipulation system of Plasmodium. The erythrocytic phase parasite has largely been
the starting point of genetic modification and clonal selection in Plasmodium (68). As
such, essential genes for erythrocytic growth are not suitable for straight knockout. The
liver stage directly precedes the erythrocytic phase, and it is highly likely that factors
involved in differentiation from liver stage to the erythrocytic stage are also essential
during erythrocytic schizogony. In addition, knockout of any gene that is also essential
in the sexual and/or sporozoite stage would never produce viable liver stage
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Plasmodium. Therefore, targeted analysis of any gene function in liver stage
Plasmodium with the aid of a knockout mutant of that gene would only be possible if
the gene is not essential in any other stages of the Plasmodium life cycle.

The

development of several conditional knockout systems in Plasmodium has huge
potential to overcome this limitation (69, 70).
Several Plasmodium species, including the human pathogen P. vivax,
differentiate into a latent form termed a hypnozoite after infecting liver cells (71). A
hypnozoite culture system and omics data have just started to emerge in the past few
years (72-74), but the induction and relapse mechanism is still largely unknown.
1.4.3: Sexual Differentiation of Plasmodium
Plasmodium sexual differentiation is one of the most heavily studied
differentiation processes among apicomplexans. The merozoites from the liver infect
RBCs to start the erythrocytic cycle of Plasmodium infection. Upon infection, the
parasite takes on a flat disk-like morphology called a ring phase, then it rounds up to
form a trophozoite, which then replicates multiple times through erythrocytic
schizogony to produce up to 32 merozoites that are released into the blood after RBC
rupture. The merozoites start another cycle of RBC infection, and either repeat the
asexual cycle again or develop into gametocytes. RBCs enclosing mature gametocytes
circulate in the bloodstream until taken up by a mosquito (Figure 1).
Gametocytogenesis, the process of developing mature gametocytes, takes 24 to 60
hours in most Plasmodium species and 9 to 12 days for P. falciparum (34, 75).
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Interestingly, the commitment to gametocytogenesis occurs one schizogony
cycle before the ultimate gametocytogenesis. Seminal experiments, first with Giemsa
staining and then with stage-specific antibody staining of Plasmodium on RBC
monolayers demonstrated that all the progeny merozoites from a single schizont either
develop into gametocytes or asexual merozoites (76, 77). Therefore, even though the
schizonts are morphologically indistinguishable, they are already committed to form
either sexual or asexual forms. Subsequently, using gender-specific antibody staining,
it was shown that a sexually committed schizont gives rise to either male or female
gametocytes exclusively (78, 79).
Several laboratory clones of Plasmodium do not form gametocytes.
Comparative genomic analysis of these clones followed by targeted gene knockouts
identified two master regulators of this commitment, AP2-G and GDV-1 (80-82). AP2G, a member of the AP2 transcription factor family, is expressed in the sexually
committed schizonts and acts as a transcriptional activator for several early gametocyte
genes (81, 82). In P. falciparum, the expression of AP2-G itself is under the control of
heterochromatin protein 1 (HP-1), which epigenetically represses the expression of
AP2-G by binding at the ap2g locus (83). GDV-1 has been shown to interact and evict
HP-1, and thus release the transcriptional repression of AP2-G (84). This puts GDV-1
upstream to AP2-G in terms of gametocytogenesis regulation. This epigenetic mode of
gametocytogenesis control is well supported by other studies. For example, several
histone

post-transcriptional

modifications
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are

exclusively

enriched

during

gametocytogenesis (85), and several epigenetic modifiers selectively inhibit the sexual
and asexual stages of Plasmodium (86).
A forward genetic approach using piggyBac transposon mutagenesis identified
16 genes essential for gametocytogenesis (87). Targeted analysis of AP2 gene family
members in P. berghei showed that knockout of AP2-G2, a transcriptional repressor,
results in a developmental arrest of gametocytes following commitment (88), and
knockout of AP2-FM, potentially a transcriptional activator, results solely in a failure
of female gametocyte development (89).
Comparative genomics, mutant library screening and targeted mutagenesis
approaches led to the identification of several other Plasmodium genes that have roles
in general gametocytogenesis, as well as male and female gametocyte production
(Table 1 in (90), (34)). However, comparative transcriptomics is arguably a more
powerful tool to understand the dynamic genetic regulation of the differentiation
process. Microarray analysis of tightly controlled timepoints has revealed a picture of
cyclic changes in the gene expression pattern in Plasmodium during erythrocytic
schizogony (91). However, similar transcriptomic or proteomic comparison between
sexual and asexual stages of Plasmodium is challenging, because gametocytogenesis is
a rare event during the erythrocytic replication stage of Plasmodium, which makes it
difficult to capture clean ‘-omics’ data from gametocytes using simple time point
resolutions (92, 93). This challenge has been partially met by FAC (Fluorescent
activated cell) sorting transgenic parasites expressing fluorescent proteins under male
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or female specific promoters (94-96). It allowed the identification of male and female
specific proteins and pathways in Plasmodium (94-96). However, male and female
gametocytes are comparatively late stages of the gametocytogenesis process in which
the sexual conversion has already taken place.

But as mentioned before, the

commitment to those stages occurs earlier in a sexual/asexual indistinguishable
schizont stage.
There is still no clean early sexually committed schizont marker. Single cell
transcriptomics has proven to be a particularly well suited technique to address this
challenge, as it allows the analysis of transcriptome from rare cell populations. The
first single cell transcriptomic experiment focusing on sexually committed schizonts
identified, among other things, two additional AP2 transcription factors and four
chromatin modifiers differentially upregulated in sexually committed schizonts,
reaffirming the role of AP2 TFs and epigenetics in Plasmodium sexual commitment
(97).

It also described a more detailed expression pattern of AP2-G.

AP2-G is

expressed in a low level in both early sexually and asexually committed schizonts.
Following a trough in expression in both populations, it is expressed highly only in
mature sexually committed schizonts (97). Since then, other studies have used this
technique to characterize the early stages of gametogenesis, and implications and
validation of their findings would surely paint a clearer picture of sexual commitment
in Plasmodium (84, 98). Importantly, one of them reported that gametocytogenesis can
happen without a committed schizont stage, which results in the formation of mixed
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plaques containing both sexual and asexual merozoites, questioning the decade-old
standard theory of gametocytogenesis commitment (98). The proposed theory behind
this mechanism is in line with the detailed temporal AP2-G expression pattern
mentioned before. The study proposes that in early schizonts, if AP2-G expression
reaches a threshold, it allows AP2-G to express again in mature schizonts, committing
them to gametogenesis. In support of this theory, they showed that artificial AP2-G
stabilization during schizogony can induce gametogenesis without going through a
committed schizogony cycle (98).
Stress on both host and parasite has long been considered to be a major signal
for gametocytogenesis (99). This belief radiates from the observation that high doses
of anti Plasmodium drugs increase the rate of sexual conversion (100) and that P.
falciparum gametocytes are preferentially developed in reticulocytes, which are
immature erythrocytes that are more readily available in anemic blood (101, 102).
Based on several empirical datasets that analysed the relationship between stress and
Plasmodium sexual conversion, a model proposed that reducing gametocyte conversion
during low levels of stress actually increase the chance of future successful
transmission whereas under highly stressed condition, the parasite allot more resources
to gametocytogenesis as a way of terminal investment for successful transmission.
High drug pressure is such a stress condition for the parasite when mortlity rate exceeds
the parasite proliferation rate or severe anaemia is such a stress condition of the host
when the mortality is imminent (99).

Recently, depletion of a serum factor called
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lysoPC has been shown to be a signal for gametocytogenesis in P. falciparum but not in
P. berghei (103). The relationship of this molecule to stress is unclear. In any case,
this aspect of gametocytogenesis requires further focus.
1.4.4: Sex-specific Maturation for Differentiation into Zygote
The gametocytes are taken up by the mosquito during a blood meal. In the
mosquito midgut, gametocytes are activated to form gametes, actively come out of the
RBC, and mate to form the zygote (Figure 1). Gamete activation or gametogenesis
involves rounding up of the gametocyte, disrupting the RBC membrane, and the egress
of mature gametes in the mosquito midgut. Change of temperature and pH from
mammalian blood to mosquito midgut, as well as the mosquito derived factor
xanthurenic acid, act as signals for gametogenesis (104, 105). A meiotic nuclear
division without diakinesis occurs within three hours of zygote formation, and the
diploid zygote transforms into a motile tetraploid ookinete (106). The ookinete
traverses the mosquito midgut epithelium to reach the basal lamina, transforms into an
immotile oocyst, and multiple haploid sporozoites are formed. The initial stages in the
mosquito vector are quite rapid; within 15 minutes the gametes come out, and the
zygotes are formed within two hours in the mosquito midgut. Ookinete development
takes 20 h to 35 h, and the oocyst development is a long process, taking around 10 to 12
days (107).
Two distinct maturation programs run in parallel in male and female
gametocytes, culminating in male and female gamete formation at the same time and
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space. Multiple proteins have been characterized that are expressed differentially in
male and female gametocytes and are essential at different stages of development of
Plasmodium gametocytes in a sex-specific manner. Knockout of these genes usually
results in a deficiency in gametocyte maturation/ gamete activation/ zygote formation/
ookinete conversion or dysfunctional ookinete formation (Table 1 in (107), (108-110)).
Indeed, global transcriptomic and proteomic comparisons of male and female
gametocytes uncover distinct expression profiles for them that are shaped by their
distinct needs (94-96).

For example, upon activation, a male gametocyte divides

mitotically three times to produce eight microgametes. The motile microgametes lyse
and egress from the RBC in a distinct fashion called exflagellation. The formation and
motility of microgametes require assembly of an axoneme, a microtubule-based
structure. The transcriptome and proteome of male gametocytes are overwhelmingly
enriched for DNA replication and axoneme formation machinery compared to the
female gametocyte (94, 96). On the other hand, the cytoplasm of zygote and early
ookinete is derived from female gamete, as the smaller male gametes mostly only
supply a copy of the genome to the female gamete during fertilization. The zygote and
early ookinete express a lot of new proteins, which is a hallmark of the stage
conversion (111, 112). To support this rapid transformation, a lot of cellular energy is
also required. In line with this point of view, the female gametocyte transcriptome and
proteome are enriched for pathways of protein synthesis and degradation, as well as
energy metabolism (94-96).
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The phenomenon of “just in time” expression observed for the mosquito to
mammalian transition in Plasmodium, where mRNAs overexpressed in salivary gland
sporozoites are kept in a translationally repressed form that are to be expressed upon
host switch, is also observed in female gametocytes during host switch. An RNA
helicase, DOZI (development of zygote inhibited) was found to be important for this
process in P. berghei (113, 114).

DOZI knockout female gametocytes produced

normal female gametes and zygotes; however, zygote to ookinete differentiation was
halted before meiosis (114).

DOZI is localized with CITH and 14 other core

components to a cytoplasmic assemblies called P granules (113).

These granules

protect overexpressed but untranslated mRNAs in female gametocytes.

In DOZI

knockout female mutants, those mRNAs are degraded (113, 114). DOZI knockout
male mutants produce ookinetes normally, suggesting this translational repression is a
female-specific program (114).

A wide variety of mRNAs including known

transcription factors required for maturation of ookinetes as well was ookinete cell
surface markers required for diverse ookinete functions are protected by these P
granules (113).

A matched transcriptomics and proteomics analysis of female

gametocytes corroborates the existence of this phenomenon, where a large number of
protein products from overexpressed mRNA are undetectable in female gametocytes
(94).

Gene ontology enrichment analysis on putatively transcriptionally repressed

genes in female gametocytes identifies meiosis as the highest enriched biological
process, which is consistent with ookinete developmental arrest before meiosis in
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female DOZI knockout mutants (94, 114).
The energy metabolism of male and female gametocytes is also divergent.
Chemical inhibition or genetic disruption of the TCA cycle and oxidative
phosphorylation is very deleterious for Plasmodium in mosquito stages but welltolerated in the asexual blood stage, as glycolysis is the overwhelmingly major source
of energy in RBC stage Plasmodium (115, 116). The gametocytes, however, show an
intermediate phenotype. Gender independent analysis of the proteome of gametocytes
suggests the presence of the TCA cycle and ETS components in them (117). Male
gametocyte activation, usually measured through the exflagellation rate of male
gametocytes, is affected by chemical inhibition of glycolysis while female gamete
activation remains unaffected (116, 118). If components of oxidative phosphorylation
are knocked out, the female gametocyte development and zygote to ookinete
transformation are disrupted, but male exflagellation is unhampered (119, 120). Taken
together, it suggests that male gametocytes depend on glycolysis-based energy
production, just like asexual Plasmodium, but the female gametocytes are not
completely dependent on glycolysis and start to shift towards mitochondrial energy
production as used by the ookinete stage.
Importantly, male and female gametocyte maturation and release are
synchronized in space and time, so that both male and female gametes can come out
together in the mosquito midgut and find each other. Therefore, even though the
gametes develop differently, they most likely respond to the same or similar
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extracellular stimuli, using similar intracellular components. For example, calcium and
cGMP signaling plays critical roles in the egress of both gametes (107, 121). Chemical
inhibition, as well as genetic disruption of cGMP-dependent protein kinase PKG and
cGMP phosphodiesterase, causes inhibition of both male and female gamete activation
(121-123). Conditional disruption of calcium-dependent protein kinase CDPK1 leads
to delayed microgamete emergence from male gametocytes, as well as a severe arrest in
ookinete development (124, 125). Molecular characterization of the later phenotype
showed that CDPK1 activity acts as a switch to turn off the transcriptional silencing
program in female gametocytes (125).

1.4.5: Zygote to Ookinete, Ookinete to Oocyst, and Oocyst to Sporozoite
differentiation
Global transcriptomic and proteomic comparison between zygote and ookinete
is inherently difficult, as gametocyte to ookinete transformation occurs very rapidly. A
few studies where this aspect of differentiation was analyzed reported the presence of
several enriched mRNAs and proteins in ookinetes stages with potential function in
invasion and metabolism (111, 112). Several gene knockouts in Plasmodium resulted
in ookinete maturation defects, but a substantive number of them are also transcribed
specifically in female gametocytes, suggesting they are likely to be regulated via the P
body mediated translational repression program (107, 126, 127). For example, the most
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commonly used ookinete markers, P25 and P28, are important for ookinete maturation
and function (128). Their transcription occurs in female gametocytes, but they are
translated only after the transcriptional repression program is turned off (114).
The differentiation of ookinete to oocyst is scarcely studied in Plasmodium, and
recent data suggest that large scale transcriptional differences exist between these two
stages (129).

Targeted disruption of several AP2 transcription factors resulted in

dysfunctional ookinete or oocyst formation (62, 63). However, temporal regulation of
these mutants along the ookinete development trajectory has not been studied in fine
detail.
Targetted analyses of AP2 TFs in P. berghei and P. yoelii suggest that a
continuous spectrum of progression from female to ookinete to oocyst is controlled by
different AP2 TFs (62-64, 89). For example, in Plasmodium berghei, AP2-FG is
required for female gametocyte maturation, AP2-O1,2,3,4 are required for ookinete
maturation and oocyst establishment, and AP2 SP1,2,3 are required for oocyst
maturation to form sporozoites (62). In P. yoelii, another putative TF, HMGB2, was
found that regulates ookinete maturation (130). An AP2 TF specifically required for
male gametogenesis has not been described yet.

1.5: Toxoplasma gondii Stage Differentiation
T. gondii gondii has extensively been used as a model apicomplexan parasite
due to relative ease of in vitro culture, earlier development of genetic tools, and
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availability of well-established animal models compared to other apicomplexans (131).
It is reported to be capable of infecting any nucleated animal cell, and is routinely
cultured in human foreskin fibroblast (HFF) cells in laboratory settings (132). Warmblooded animals are intermediate hosts of the parasites, which become infected by
ingestion of oocysts (found in the feces of cats, the definitive host) or tissue cysts
residing in the tissues of an animal (Figure 2).

In the gut, tissue cysts release

merozoites that infect intestinal epithelial cells where they asexually replicate by
endodyogeny, a special form of replication characterized by forming two daughter cells
within a mother cell and ultimately consuming it. Asexual replication usually gives rise
to eight tachyzoites that lyse the host cell and infect nearby cells. If tachyzoites gain
access to leukocytes, they migrate to different tissues. In immunocompetent hosts,
tachyzoites ultimately differentiate into bradyzoites, a slowly replicating quiescent form
that is subsequently enclosed by a cyst wall within the host cell. The number of
bradyzoites in the tissue cysts range from two to hundreds. This encystation process
establishes a lifelong asymptomatic chronic infection of T. gondii. In the case of
immune suppression of the host, e.g. by infection or chemotherapy, tissue cysts can be
reactivated and the bradyzoites differentiate back into tachyzoites. Eating raw meat
containing tissue cyst disseminates the infection to a new host (28).
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1.5.1: Tachyzoite-Bradyzoite differentiation
1.5.1.1.: Lessons from the Induction Signals
Stress has been established as the key environmental stimulus for tachyzoite to
bradyzoite differentiation. It can be applied in various forms like temperature or PH
change, drug administration, activation of the host immune system, and metabolic
inhibition (133). Interrogation of how such diverse stresses induce the same phenotype
of tachyzoite to bradyzoite differentiation led to the characterization of eIF2α
(eukaryotic Initiation Factor 2 alpha) phosphorylation, a known marker of the
eukaryotic stress response, in T. gondii (134). eIF2α is a highly conserved transcription
initiation factor in eukaryotes that is repressed by phosphorylation (135). Several
above-mentioned stressor classes induce phosphorylation of eIF2α in T. gondii, and this
phosphorylation mark is kept in bradyzoites, suggesting a link to this phosphorylation
to bradyzoite differentiation (136).

Chemical inhibition of phosphorylation led to

reduced bradyzoite conversion, and also reduced tachyzoite lytic proliferation both in
vivo and in vitro (137). On the other hand, inhibition of eIF2α dephosphorylation
increases the bradyzoite conversion rate and inhibits the reactivation of bradyzoites
(138). These data indicate that eIF2α phosphorylation is necessary for bradyzoite
differentiation. Four classes of eIF2α kinases have been identified in T. gondii that
phosphorylate eIF2α in under distinct stress conditions (134, 136, 139-141). Gene
knockout of two of these kinases inhibits eIF2α phosphorylation and the mutant
tachyzoites showed reduce infectivity in in-vitro cell culture after specific stress
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inductions (139, 140). Replacing the wild type eIF2α with a phosphorylation deficient
eIF2α phenocopies both of the kinase knockouts (139, 140, 142). Additionally, death is
delayed in mice infected with these mutants (139, 140, 142).

Therefore, eIF2α

phosphorylation is also important for the lytic tachyzoite. In several other systems,
phosphomimetic versions of eIF2α have been described (143-146). In T. gondii, such
mutant eIF2α expression has not been described yet. It would be interesting to observe
if phosphomimetic eIF2α expression is possible in T. gondii and if yes, would it be
sufficient to drive tachyzoite to bradyzoite differentiation.
Several stressors that induce bradyzoite differentiation hamper mitochondrial
function. Atovaquone, a drug that targets apicomplexan mitochondrial activity, was
found to be ineffective against a clone of T. gondii that spontaneously differentiates
into bradyzoites (147). It led to the testing and validation of atovaquone and some
other drugs that supposedly act on mitochondria to be inducers of bradyzoite
differentiation (147).

IFNγ, another inducer of bradyzoite differentiation, induces

macrophages to produce nitric oxide, which in turn reacts with Fe-S clusters of the
mitochondrial respiratory chain, rendering the organelle dysfunctional (148). When
bradyzoite and tachyzoite extracts were tested for the enzymatic activity of several
glycolytic and TCA cycle enzymes, bradyzoite extracts showed higher activity for
glycolytic enzymes (149). Recently, it has been shown that knocking out hexokinase,
the first enzyme in the glycolytic breakdown of glucose, severely blocks bradyzoite
formation in mouse brain, but only modestly affects lytic replication of tachyzoites
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(150). Isotope-labeled metabolite tracking showed that tachyzoites can use glutamine
in the TCA cycle to generate energy in the absence of glucose utilization, and also
synthesize glycolytic intermediates from gluconeogenic pathways (150).

Taken

together, all these observations suggest that mitochondrial respiration is important for
tachyzoite energy production, but not so critical for bradyzoite energy production.
One bradyzoite inducing compound, called compound 1, greatly exemplifies the
role of the host cell on bradyzoite differentiation (151). This compound was initially
identified as an inhibitor of cGMP-dependent PKG (152, 153).

Interestingly,

pretreatment of HEF cells with compound 1 resulted in the induction of bradyzoite
differentiation (151). Microarray analysis of host cells revealed that the expression of
cell division autoantigen-1 (CDA1) is 47-fold upregulated in response to compound 1
treatment.

RNAi-mediated silencing of CDA1 rendered parasites insensitive to

compound 1, whereas overexpression of CDA1 induced differentiation similar to the
level of compound treatment (151). CDA1 can inhibit cellular growth, and also is
implicated in tumorigenic and DNA damage response pathways in mammalian cells
(154).

Indeed, cell types that do not grow rapidly, like terminally differentiated

neurons or muscle cells, are more permissive to bradyzoite cyst formation (155, 156).
The molecular mechanism of how the host cell’s replicative potential is transmitted to
the parasite is still unknown. Different cell types respond differently in terms of their
global gene expression pattern and common pathways have not been identified that can
robustly explain the host cell-type tropism of bradyzoite differentiation (155, 157).
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1.5.1.2: Lessons from the -Omics Studies
Tachyzoites and bradyzoites differ extensively in the global gene expression
pattern. Early realization of this fact came from stage-specific antigen detections in
these two forms.

It led to stage-specific cDNA library constructions and the

identification of stage-specific genes (158-161). The highly used tachyzoite specific
marker SAG1 and bradyzoite specific marker BAG1 were identified in such a manner
(159, 161). Subsequently, the development of techniques like suppression subtraction
hybridization (SSH) (162), microarray (163-171), comparative RNA-seq (172-176),
and mass spectrometry-based comparative proteomics (177) have allowed comparison
of the global gene expression patterns in tachyzoites and bradyzoites in high temporal
resolution along the pathway of differentiation. Several major insights are gained from
these “-omics” data that are also validated by other more targeted experiments. For
example:
1) The transcriptome and proteome of bradyzoites remain dynamic for a long
time even after the formation of bradyzoites in the mouse brain, and only become more
static three months post-infection (173). This goes well with the observation that
bradyzoites within tissue cysts are not completely dormant; instead, they continue to
replicate and run other metabolic functions at a very low rate (169, 178, 179).
2) Several metabolic enzymes and some other proteins have isoforms in T.
gondii, and they are differentially expressed in tachyzoites and bradyzoites. This was a
well-known phenomenon that was discovered even before the use of -omics studies on
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T. gondii (180, 181).
3) The cell cycle progression of tachyzoites shows two distinct stages of
transcriptome, G1 phase and S/M phase (182). The transcriptome of a bradyzoite
formation deficient mutant under stress condition has more similarity to S/M phase
(169, 171). This supports the notion that during bradyzoite differentiation, a G2-like
phase of the cell cycle is activated that is normally present in the eukaryotic cell cycle
in between S and M phase but is not observed in the T. gondii cell cycle (183).
4) The tachyzoite transcriptome is differentially enriched for proteins in the
TCA cycle and oxidative phosphorylation (174). This supports the currently held view
that bradyzoites are more dependent on anaerobic glycolysis for energy production
(149, 150).

1.5.1.3: Role of Epigenetic Regulators and Transcription Factors
The high number of differentially expressed genes between tachyzoite and
bradyzoite suggests the presence of a global regulator of gene expression in this
differentiation process.

Epigenetic changes and transcription factors are obvious

suspects that can bring such a high variation of global gene expression. A common
epigenetic DNA modification in eukaryotes is cytosine methylation, catalyzed by DNA
methyltransferases. DNA is more methylated in the bradyzoite stage compared to the
tachyzoite stage. There are two DNA methyltransferases in T. gondii, both of which

30

are upregulated in the bradyzoite stage (184). On the other hand chemical inhibition or
genetic knockout of epigenetic histone modifiers also affected the bradyzoite
differentiation rate (171, 184-186).
The well-established role of AP2 TFs in Plasmodium differentiation motivated
researchers to look for the role of their T. gondii homologs in bradyzoite differentiation.
Knockout or overexpression of several AP2 TFs in T. gondii positively or negatively
affected bradyzoite differentiation and cyst formation. However, none of these mutants
could completely turn on or turn off the differentiation despite affecting the expression
of several stage-specific genes (187-191). For example, AP2IX-9 expression peaks at
two days post bradyzoite induction and declines thereafter, whereas AP2IV-3
expression rapidly increases also at day two and slowly keeps increasing or is
maintained thereafter (189). AP2IX-9 is a putative transcriptional repressor that is
shown to repress the expression of bradyzoite marker BAG1 (191). On the other hand,
AP2IV-3 is a putative transcriptional activator that is demonstrated to activate BAG1
expression (189). In accordance with their role in BAG1 transcriptional regulation,
AP2IX-9 and AP2IV-3 knockout mutants enhanced and reduced bradyzoite
differentiation respectively (189). The overlap in the expression pattern of these two
transcription factors exemplifies the highly dynamic nature of the early stages of
bradyzoite differentiation. Indeed, parasites within a single vacuole or even a single
parasite express markers of tachyzoites and bradyzoites together, during both
bradyzoite-to-tachyzoite and tachyzoite-to-bradyzoite differentiation (192, 193).
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The development of the CRISPR-Cas9 mediated forward genetic approach has
been developed recently in T. gondii (194).

With this approach, the bradyzoite

formation phenotype was analyzed in ~200 knockout mutants (176). The tested gene
set contained stage-specific genes, as well as known and putative transcription factors.
Knockout of a single TF, BFD1, showed a bradyzoite formation deficiency phenotype.
Furthermore, targeted disruption of BFD1 followed by single-cell RNA-seq based
phenotypic characterization demonstrated that BFD1 is both necessary and sufficient
for bradyzoite differentiation (176). This is the first identification of a master regulator
of bradyzoite differentiation. How this TF itself is regulated in response to different
classes of stress is still to be determined.
1.5.2: T. gondii Sexual Differentiation
Cats are the definitive host of T. gondii. They can get infected by tachyzoites,
bradyzoite containing tissue cysts, and sporozoite containing oocysts. The preferred
form for causing feline infections seems to be tissue cysts, as its prepatent period (time
to shed oocyst in the feces) is 3 to 10 days, followed by tachyzoites (prepatent period
>13 days), and oocysts (>18 days) (28).

Life cycle progression in cat intestinal

epithelial cells, determined by electron micrograph and described in only a few
publications, is as follows:
The sporozoites from oocysts start infection, and replicate asexually via the
tachyzoite replication cycle. Tachyzoites differentiate into bradyzoites, most likely due
to immune system derived stress.

The bradyzoites differentiate into five
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morphologically distinct forms in a stepwise manner, potentially asexually replicating
multiple times within each form. Finally, from a schizont-like form, merozoites appear
that differentiate into male and female gamonts in the cat intestinal epithelium. Male
gametes fertilize female gamonts to form zygotes, which are then differentiated into
oocysts. Rupture of infected epithelial cells releases oocysts into the lumen that are
ultimately excreted in the feces. Mitosis and meiosis produce two sporocysts, each
containing four sporozoites (Figure 2). For a more detailed description of this life cycle
with a description of each form, see reference (28). Until very recently, the bradyzoite
to oocyst differentiation could only be observed in feline intestinal epithelial cells in
vivo, which is a difficult experimental system to get access to (195).

Therefore,

molecular characterization of the intermediate stages is very limited (196, 197).
Despite the fact that cats are not a readily accessible experimental system,
several comparative transcriptomics studies have been performed along this line of
differentiation. Transcriptomes from three stages of oocyst maturation and merozoites
were compared with in vitro tachyzoites and bradyzoites using microarray (198, 199).
More recently, RNA-seq has been used to compare the transcriptome of merozoites,
five separate timepoint samples along the sexual differentiation path from T. gondii
infected cat intestinal epithelial cells, and tachyzoites (31, 200). Combining data from
these experiments, stage-specific expression profile was determined for each of the
stages and was used heavily to characterize a mutant parasite whose MORC gene can
be conditionally knocked out (201). MORC is an ATPase protein that provides energy
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for epigenetic modification of histone by histone deacetylase 3 (HDAC3) (201).
Conditional knockdown of MORC, as well as chemical inhibition of HDAC3, silenced
a large set of target genes (validated by Chip-seq), which are mostly enriched in
gamonts and somewhat enriched in oocysts and bradyzoites (184, 201). It led to the
conclusion that epigenetic histone modification by the HDAC-MORC complex
suppresses parasite differentiation towards sexual replication.

These are the only

characterized global regulators of the T. gondii sexual differentiation pathway so far
(201).
A long-standing question in the field of T. gondii was why the sexual cycle only
takes place in the feline intestine. Recently, it was shown that the cat is the only
mammal that lacks a specific fatty acid breakdown enzyme, which allows the buildup
of linoleic acid in cats that triggers the sexual differentiation (202). Both linoleic acid
supplementation in in vitro culture and inhibiting the degradation of linoleic acid in
mice allowed the sexual cycle to commence both in vitro and in vivo in a mouse model
(202).

Even though the molecular detail of this signaling is still unknown, this

discovery has made the experimental system of T. gondii sexual differentiation hugely
accessible compared to the previous state (203). It could potentially lead to a better
molecular characterization of T. gondii differentiation along the route of sexual stages.
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1.6: Cryptosporidium Stage Differentiation
Cryptosporidium species are parasites of the vertebrate gastrointestinal tract
(204). They can complete their life cycle within a single host. Many of the reported
species can infect multiple hosts, both naturally and experimentally. For example, C.
hominis is the major human pathogen of the genus and can also infect gnotobiotic
piglets experimentally. C. parvum can infect both humans and cows naturally, and
immunocompromised mouse models experimentally (205).

Once considered as a

coccidian, phylogenetic analysis now shows that this single genus constitutes a separate
clade of Apicomplexa, which is phylogenetically more similar to gregarines than
coccidians (206).
Oocysts are the infectious forms of the parasite that disseminate through the
fecal oral route (Figure 3). Four sporozoites come out from an oocyst and infect
intestinal epithelial cells (IECs). They form a parasitophorous vacuole (PV) within the
host cell that is localized just under the plasma membrane, a peculiar localization that
has often been described as intracellular but extracytoplasmic (207).

Within the

vacuole, Cryptosporidium transforms into trophozoites that develop into type I meronts
containing six to eight type I merozoites, which come out and infect nearby IECs
within a day post infection. After several rounds of this asexual replication, they
differentiate into type II meronts containing type II merozoites, which in turn develop
into gametocytes after infecting the IECs. Microgametocytes produce around 16 male
gametes that come out and fertilize uninucleate female gametocytes residing in a host
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cell. Gametocytes start to emerge 42 hours post C. parvum infection in vitro and they
are the terminal form of Cryptosporidium differentiation in the human colorectal
carcinoma cell line HCT-8, which is commonly used for in vitro cultivation. In vivo,
fertilized zygotes differentiate into oocysts and, during their development, meiotic cell
division within the PV forms four sporozoites.

Two types of oocysts have been

described for Cryptosporidium, thin-walled oocysts that autoinfect the host and thickwalled oocyst that are excreted into the environment (204, 208, 209).
Cryptosporidium infection is asynchronous, which makes it difficult to
determine the number of asexual cycles before commitment to gametogenesis (204,
208, 209).

The different stages are mainly described via electron microscopic

observations (208, 210).

Until very recently, there were no clear markers to

differentiate different stages of the Cryptosporidium life cycle using light microscopy.
The dogmatic view in the field is that sexual differentiation is an obligate step
following several rounds of asexual replication. However, it is hard to determine if
asexual cycles continue in parallel to sexual differentiation within the vertebrate host,
because even if they are observed together, the asexual forms might result from
subsequent rounds of infection from the autoinfective thin walled oocysts. Commonly
used cell culture methods cannot support the life cycle completion in vitro, and cultures
collapse after the majority of the parasites progress into gametocytes (211). Without
molecular characterization, it is also difficult to determine if in vitro progression to
gametocytes is predetermined or an induced event caused by in vitro culture conditions.
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Recently, using a cleverly designed transgene cassette for Cryptosporidium that
only supports fluorescent protein expression upon fertilization, it was shown that
fertilization is blocked in the HCT8 cell culture system (212). One of the possible
explanations for this observation can be that the gametocytes do not fully mature in the
culture. Transcriptome comparison of Cryptosporidium at 48 hours and 96 hours post
infection using RNA-seq reported that around 500 genes are differentially expressed
between in vivo and in vitro conditions (213). However, the asynchronous nature of
the parasite infection inhibited assigning differentially regulated genes to specific
stages of the life cycle. 59 of the upregulated proteins in vivo are secreted proteins that
include one of the major oocyst wall proteins and several other uncharacterized large
glycoproteins that are potential oocyst wall components.

In comparison, only six

upregulated proteins in vitro are secreted proteins. While the proteins upregulated in
vivo might be required for female gamete formation, they also might be expressed
following fertilization. Therefore, macrogamete formation deficiency could not be
completely verified in this study (213).

A cleaner comparison of macrogamete

development was performed by expressing a fluorescent protein under a female specific
promoter and FAC sorting macrogametes from in vivo and in vitro conditions for RNA
seq (212).

This comparison did not suggest any major dysregulation of female

gametocyte specific gene sets except that in terms of global gene expression in vivo
females had comparatively more similarity to sporozoites compared to in vitro females
(212). This observation can be explained by the fact that FAC sorting of the in vivo
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population also isolated zygotes and immature oocysts, as they also fluoresce in this
system (212). Potential microgamete development deficiency in vitro has not been
tested robustly yet.
One of the recently developed stem cell-derived platforms that supports oocyst
production in vitro utilizes differentiation of mouse intestinal stem cells at air-liquid
interface (ALI) as a culture platform (214). The host cell differentiation is blocked in
the absence of ALI condition, and consequently, Cryptosporidium growth is also
significantly affected. This system is well suited to test the effect of host cell gene
expression on Cryptosporidium differentiation.

Comparison of ALI and non-ALI

culture host cell transcriptomes suggest that several pathways are significantly
differentially regulated between those two conditions.

Specifically, the energy

metabolism of the ALI culture significantly shifts from glycolytic to mitochondrial
respiration (214).

Taken together with the above-mentioned studies about

macrogamete development, this suggests that the discontinuation of Cryptosporidium
growth in different cancer cell lines may actually result from the differences in host cell
characteristics rather than gametocyte development deficiency. However, the exact
molecular mechanism of this phenomenon is still to be elucidated.
The transcriptome of sporozoites at varying in vitro culture time points has
revealed that Cryptosporidium has a highly dynamic transcriptional regulation as it
progresses through its life cycle, and there are numerous stage specific genes (213, 215,
216). A high throughput qRT-PCR based analysis has the highest temporal resolution
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of transcripts so far (215). This study captured seven different time points ranging
from 2 hours to 72 hpi in vitro. In combination, two RNA-seq studies also assayed the
transcriptome of 2, 24, 48 and 96 hpi, as well as oocysts and sporozoites (212, 216).
Despite differences in host cell lines, sampling times, methods used, and analyses
modules, these three sets of data are fairly consistent and provide similar conclusions
regarding several broad aspects of life cycle progression.

For example, the gene

expression pattern in intracellular stages is more diverse compared to sporozoites and
oocysts, with a huge shift towards rapid transcriptional activities observed at early
intracellular timepoints. Later time points in all the experiments showed enrichment of
oocyst wall proteins and meiosis associated proteins. Importantly, the later time points
contain a mixture of both male and female gametocytes in these experiments (213, 215,
216).

RNA-seq mediated comparison between FAC sorted female parasites and

asexual stages verified that both of the above-mentioned protein classes are enriched in
female gametocytes (212). One interesting observation from both of the bulk RNA-seq
experiments was that mRNA of one paralogue of two lactate dehydrogenase genes of
Cryptosporidium is selectively highly expressed in the sporozoite population (213,
216). In a microarray experiment of oocysts, the same observation was reported (217).
The potential functional significance of this observation is still to be realized.
The high temporal resolution of the qRT PCR dataset noted above makes it
suitable for the exploration of co-expressed gene clusters. Indeed, in the original
publication, they divided the genes into nine clusters based on their temporal
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expression profiles (215). Subsequently, another study used the same dataset and,
using an optimized parameter for clustering it described 200 different clusters of coexpressed genes (218). Several short DNA motifs were enriched in the promoter
elements of several clusters (218). An in vitro AP2 TF DNA binding assay showed that
some of the identified motifs are recognized by multiple Cryptosporidium AP2 TFs
(219). For example, the motif “GCATGCA” was found to be overrepresented in 33 of
200 clusters (218). The DNA binding assay showed that slight variations of this motif
are identified by four different AP2 TFs. Taken together, it suggests that AP2 TFs play
important roles in stage-specific transcription of Cryptosporidium genes.
Several recent breakthroughs have made studying the differentiation of
Cryptosporidium life cycle progression more amenable.

The parasite is now

genetically manipulatable using CRISPR-Cas9 technology (220), distinct phases of its
life cycle can be identified by stage specific antibodies (221), completion of its life
cycle is possible in vitro (214, 222-226) and stage specific assays are available (209).
Together, these developments constitute a strong toolbox to progress our understanding
of the Cryptosporidium life cycle beyond microscopic observation to molecular
characterization.
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1.7: Eimeria Stage Differentiation
Eimeria species are coccidian apicomplexans that can infect all classes of
vertebrates and some invertebrates (227). Each species is considered to be specific for
a single host, within which they complete their whole life cycle (227). Several Eimeria
species are parasites of chickens that cause huge economic losses in the poultry
industry. The most well studied species of them is Eimeria tennela.
Eimeria oocysts form sporocysts within them in the environment (Figure 4).
Upon ingestion, they are released in the chicken gastrointestinal tract. Sporozoites
come out of the sporocyst in the small intestine and infect the intestinal epithelial cells.
After several rounds of asexual schizogony, where multiple merozoites from a schizont
start another round of replication, gametes emerge, fertilization takes place, and
subsequently, the zygotes differentiate into oocysts that are excreted in the feces (228).
Based on the observations of morphologically different schizonts that emerge in a timedependent manner after chicken infection, the dogmatic view is that Eimeria species
are genetically programmed to replicate for a fixed number of asexual schizogony
cycles before differentiating into gametocytes (228, 229).

For example, upon E.

tennela infection, first generation schizonts are observed at day 1 and 2 post-infection,
the second generation of schizonts, which are larger and contain more nuclei than the
first generation, are observed on day 3 and 4 post-infection, and third generation
schizonts, which are smaller than both of the earlier schizont stages and contain up to
16 merozoites, are observed after 4 days of infection (228, 230). Merozoites from the
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third stage schizont develop into gametocytes that start to emerge at day 5, which
ultimately form the zygote. Oocysts are abundant in the feces on day 6 to 7 post
infection (228, 230).
Several controlled experiments support the theory of preexisting genetic
programs for the number of asexual replication cycles. For example, in a study testing
this theory, merozoites were collected from chicken intestine 94 hpi (hours postinfection) and used to infect naïve chickens by direct intestinal injection (231). This
inoculum is supposedly enriched for the second generation of merozoites and, in
agreement with the theory, none of the earlier stage schizonts were observed in the
naïve chicken. Third stage schizonts, gametocytes, and oocysts emerged at earlier time
points compared to chickens infected with oocysts (231). Recently, RNA-seq and SSH
techniques were used to determine the gene expression pattern of E. necatrix
merozoites collected at 136 and 144 hpi. The two populations were considered the
second and the third generation of merozoites respectively. A high number of genes
were found to be differentially expressed and they were classified into second or third
generation-specific genes (232, 233).
However, in vivo infection of Eimeria is asynchronous which makes it difficult
to differentiate different stages of schizont based on size only (228, 229).
Consequently, merozoite isolation at a certain time point post-infection would likely
result in a diverse set of merozoites from different replication cycles. Additionally,
instead of a replication number clock, there might be environmental signals that drive
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the differentiation and as such, the parasites at different timepoints post infection might
be at different stages of development/differentiation, irrespective of the number of
schizogony cycles that they went through. Therefore, in the absence of specifically
defined markers for each schizogony cycle and/or without genetic validations about the
existence of distinct schizogony stages, the theory of a genetically determined
replication number cannot be properly tested.
Attempts of attenuated vaccine development present another approach to test
this phenomenon. It has been shown that repeated isolation of early oocysts and their
selection by serial passage gives rise to less virulent precocious lines of Eimeria whose
prepatent time decrease significantly from the parent parasites (234-237).

Most

commonly, fewer asexual replication cycles have been attributed to such shortened
prepatent time of precocious lines (234, 237, 238). Searching for a potential genetic
basis of the fewer asexual cycles that occur, one study crossed a precocious line with its
parent and identified a genetic linkage in chromosome 2 associated with the shorter
prepatent time phenotype (239). Recently, another study looked for differences in
transcriptional activity of a precocious and its parent line and suggested potential
differences exist in the expression of DNA replication related genes at merozoite stages
(234). Heritable epigenetic changes can also cause such a phenomenon; however,
epigenetic comparison between a parent and a precocious line has not been described
yet.
To probe the commitment towards sexual differentiation in Eimeria, a study
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used periodic acid-Schiff (PAS) staining in primary chicken kidney cell culture and
reported that PAS-positive third generation schizonts form PAS-positive third
generation merozoites that ultimately form PAS-positive macrogametocytes (240). The
opposite was observed for microgametocyte development. This suggests that parasites
are committed to forming either male or female gametocytes one replication cycle
before the ultimate differentiation, similar to the Plasmodium parasites. However, this
phenomenon has not been tested robustly with modern techniques.
Several studies have used comparative transcriptomics and proteomics analysis
to understand the regulation of the life cycle progression of Eimeria (200, 232-234,
241-243). Analysis of the proteome of oocysts, in vitro sporulated sporozoites, and
merozoites isolated from infected chickens suggested that merozoites express proteins
involved in oxidative phosphorylation more abundantly, whereas glycolytic enzymes
are expressed almost equally between sporozoites and merozoites (242). Another study
used RNA-seq to determine differential expression of genes between sporozoites,
asexual merozoites (collected 112 hpi) and gametocytes (gender independent, 134 and
144 hpi) (200). Genes that were upregulated in gametocytes contained enzymes for
protein glycosylation and proteases, both of which classes were previously described as
upregulated in gametocytes in independent studies (244, 245). Comparison of this
dataset with Plasmodium sex-specific transcriptomic datasets showed that homologs of
both male and female specific Plasmodium genes were upregulated in gametocytes in
this dataset (200).

Antisera raised against some of these proteins successfully
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differentially identified male and female gametocytes (200), which could be very
helpful for future differentiation studies.
Recently, a breakthrough publication in E. tenella described new gene knockout
techniques in Eimeria using CRISPR-Cas9 mediated genetic manipulation techniques
(246). The Cas9 protein was also successfully integrated into the genome, which
creates a very amenable system for mutant library preparation (246). This study also
demonstrated a successful knockout of 10 of the 33 putative AP2 TFs in the E. tennela
genome, suggesting the others were essential (246).

With this newly developed

technique, long-standing questions in Eimeria life cycle progression can be addressed
in a more comprehensive way. One still standing roadblock in the field is the absence
of an easily manipulatable continuous culture system.

1.8: Stage Differentiation of Piroplasms
Piroplasms are a group of hematozoan apicomplexan parasites that infect blood
cells of vertebrates for asexual replication and blood-sucking ticks for sexual
replication (247).

Phylogenetically, they are the closest relatives of Plasmodium

among the parasites discussed in this review. Babesia and Theileria infect cattle while
Babesia can also infect humans as a dead-end host (Figure 5). Hard ticks of the family
Ixodidae are their definitive host who takes up the mature gametocytes of these
parasites residing in RBCs of mammalian hosts (248).

In the tick midgut,

gametogenesis and fertilization takes place, zygotes are formed in the midgut cells,
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followed by meiosis to produce kinetes. Kinetes migrate to the salivary gland of the
tick via hemolymph, and differentiate into sporoblasts that contain sporozoites, which
are the vertebrate infective form. Babesia sporozoites directly infect RBCs, while
Theileria sporozoites first infect leukocytes.
leukocytes then infect RBCs.

Theileria merozoites released from

The asexual replication cycle and occasional

gametocytogenesis occur within RBCs, ultimately forming mature gametocytes. Even
though there are several steps in the piroplasm life cycle where differentiation occurs,
our knowledge about molecular mechanisms governing these steps is extremely limited
(248).
1.8.1: Theileria
Most of the pathogenic Theileria species can cause an oncogenic transformation
of the leukocytes that they infect (249). They replicate via schizogony inside the
parasitophorous vacuole within a transformed cell, and when the host cell is mitotically
divided, they are distributed into daughter cells (250). Importantly, this transformation
is reversible. Typically, Theileria are cultivated in vitro in transformed leukocytes
(249). Different aspects of this transformation process have been studied relatively
more extensively than progression of the parasite beyond this stage of the life cycle
(251). They progress to the RBC stage by producing merozoites that egress from the
leukocytes. The observation that the number of nuclei in the schizont increases before
merozoite formation led to the theory that a high ratio of DNA compared to protein in
the parasitophorous vacuole signals merozoite differentiation (252). Inhibition of DNA
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synthesis using a cell cycle progression inhibitor induced early differentiation, whereas
a mitochondrial protein synthesis inhibitor prolonged the time before differentiation
(253). This led to a more refined theory that when specific protein factors in the
parasitophorous vacuole reach a threshold, it induces commitment and the higher ratio
of DNA in the earlier theory on commitment is just a facilitator for higher
transcriptional activity (i.e. higher number of genomic copy allows higher transcription
of a specific factor) in the multiple nuclei containing parasitophorous vacuole (253). It
was subsequently shown that a protein overexpressed during differentiation is
transcriptionally regulated by putative transcription factors that are also enriched during
differentiation (254). This supported the notion that reaching the threshold of specific
factors drives differentiation (254). Increasing culture temperature is the most common
way of inducing merozoite differentiation in Theileria (252-255). It was shown that the
protein synthesis rate of the parasite increases at the higher temperature (253). Finally,
stage-specific overexpression of 3 genes was verified by northern blotting (255).
All these pre-omics era studies suggest that there is a stage specific expression
of genes that drives differentiation. Indeed, transcriptomic and proteomics studies
confirm that there are stage specific expression profiles of genes in different stages of
the Theileria life cycle, just like all the other Apicomplexa (256-258). However, even
though there are markers of different stages, wet lab experimental identification of a
master regulatory element is still missing. In silico analyses have shown that Theileria
contains several AP2 TFs, and expression profiles of several of those AP2 TFs are also
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stage specific (259, 260). The genetic knockout system is still not developed for
Theileria, however, so potential experimental validation approaches are limited at this
point (261).
1.8.2: Babesia
Several species of Babesia can be continuously cultured in-vitro within RBCs
during their asexual replication cycle (262).
documented for Babesia yet (248).

No schizogonic replication has been

In the mammalian blood, some parasites

differentiate into gametocytes, which are activated in the tick midgut to form gametes
(248). Induction of gametocytogenesis, as well as gametogenesis, can be achieved in in
vitro blood culture of Babesia (263-265). Stressing the parasites with anti-Babesia
drugs induces gametocytogenesis, whereas induction with xanthurenic acid or tick
extract induces both gametocytogenesis and gametogenesis (265, 266). There are three
validated marker genes of gametocytogenesis, two of them are expressed in kenetes
also (267, 268).
Hap2 is a well documented male gamete specific protein in different systems,
and it is functionally important for gamete fertilization (269). Reducing Hap2 activity,
either by functional inhibition using antibodies or by genetic knockout, inhibits zygote
formation, suggesting a similar role for Hap2 in Babesia as seen in the other systems
(270, 271). A putative methyltransferase is only expressed in tick stages (268). In
addition to these markers, there are other potential stage specific proteins in Babesia
that are identified through proteomics based analysis (272-274).
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Global regulators of differentiation have yet to be identified for Babesia, and
none of the AP2 TFs have been studied for differentiation in a targeted way yet (260).
As a gene knockout system in Babesia is available (271, 275), knockout mutant derived
validation of a master regulator is possible, and the already established stage specific
markers would greatly help in that process.

1.9: Similarities and Differences in Stage Differentiation Between Apicomplexan
Parasites
During almost the entirety of their life cycle, all the discussed apicomplexan
parasites have a haploid nucleus. Zygotes are the only diploid stage, and in most cases,
they are very short-lived because of the subsequent meiotic division. Whether there are
common underlying mechanisms of initiation of meiosis in response to the diploid state
of the nucleus is not known.
Sexual differentiation of the Apicomplexa starts with gametocytogenesis, which
gives rise to male and female gametocytes. The two gametocytes develop with highly
divergent gene expression patterns, but they normally emerge together during the
course of infection. This suggests a two-step process of gametocytogenesis induction.
First, a gender independent commitment step, and subsequently, a gender-specific
differentiation pathway. This has been well characterized in Plasmodium where Δap2g mutants do not form any gametocytes whereas Δap2-fg are only deficient in female
gametocyte maturation.

A sexually committed schizont stage is observed in
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Plasmodium within which the two above mentioned steps likely take place. Hints of
the same phenomenon have been also observed in Eimeria, where the schizonts in the
last cycle are morphologically distinct from the earlier cycles, and in Cryptosporidium,
where a type II meront is observed before the emergence of gametocytes. Whether
these two stages are analogous to the sexually committed schizont of Plasmodium has
not yet been tested with molecular techniques.
The time interval between commitment to gametocyte formation and the
ultimate release of gametocytes differs between different apicomplexan species. For
hematozoans, mature gametocytes of both sexes need to come out from the host cell at
the same time in the vector midgut. In the case of Coccidians and Cryptosporidium,
only the male gametes egress from the host cells, after which they fertilize mature
female gametocytes residing in other host cells. In any case, gametocyte maturation of
both sexes must be synched in time for successful fertilization.
Gametocyte development pathways seem to be well conserved within
apicomplexans, as multiple transcriptomics and proteomics studies have shown that
homologous proteins are expressed in a sex-specific manner for all the apicomplexans.
For example, meiosis-related genes are expressed during the maturation of female
gametocytes in different parasites, presumably so that the proteins for meiotic division
are readily available soon after the fertilization. On the other hand, expression of
HAP2, a well-characterized gamete fusion protein, is restricted to male gametocytes in
different apicomplexans.
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Commitment to the next step of differentiation occurs before the ultimate stage
conversion in almost all of the differentiation processes. The only exception seems to
be the tachyzoite to bradyzoite differentiation, which is more dynamic. However, this
particular differentiation is also unique in the sense that it is reversible. Even including
bradyzoite differentiation, identified global regulators of differentiation in different
apicomplexans are highly common between species. The family of AP2 TFs plays key
roles in all the differentiation processes. Post-translational regulation is also commonly
observed in many differentiation processes. For example, inhibition of translation
initiation by phosphorylation of eIF2α is observed for Plasmodium sporozoite to liver
stage conversion, and in tachyzoite to bradyzoite conversion.

However, this

conservation can be artificially biased, as the selection of global regulators for in-depth
studies is often guided by what is already known in other apicomplexans. Indeed, when
a relatively unbiased mutant library screen was used to identify key regulators for
bradyzoite differentiation, it identified a myb domain containing TF, which was never
implicated in apicomplexan differentiation before (176).
Stage specific alteration in energy metabolism is also a well conserved feature
of apicomplexan differentiation.

Some stages are more dependent on anaerobic

glycolysis for energy production, whereas other stages are more reliant on oxidative
phosphorylation.

The role of epigenetic modification of chromatin structure in

differentiation is starting to emerge in apicomplexans, and will likely be recognized to
play a role in many apicomplexans after further study.
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1.10: Future perspectives
Several technological advances in recent years have made studies of
apicomplexan differentiation more accessible. Two techniques have potential high
values in understanding differentiation across multiple apicomplexan species—namely,
single cell RNA-seq and CRISPR-Cas9 mediated mutant library preparation.
It is often difficult to differentiate different stages of the apicomplexan life cycle
due to their asynchronous growth and lack of robust stage-specific markers.

In

addition, the lack of an easily manipulatable in vitro culture system hinders studies of
different apicomplexans. Theoretically, single cell transcriptomics can overcome all
these challenges. Great examples of this are the two single cell transcriptional atlases
of Plasmodium and T. gondii (129, 172). From both of these studies, it is apparent that
single cell transcriptomes from parasites at different stages of their life cycle cluster
with unguided algorithms in a stage specific manner. Deductive reasoning can be
applied to such datasets from our knowledge on well-studied apicomplexans to
determine the identity of each cluster. As transcriptomes are generated from single
cells rather than a population, they are theoretically more suitable for identifying sets of
co-expressed genes. Additionally, it is almost the ultimate phenotypic characterization
tool when the phenotype is the differentiation capability .
The second technique, CRISPR-Cas9 mediated mutant library preparation, is
relatively restricted to parasites with already established robust transfection and genetic
manipulation systems. It is already available for Plasmodium and T. gondii, and also
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probably for Eimeria (58, 194, 246). CRISPR-Cas9 mediated library generation allows
preparation of an unbiased mutant library, as well as relatively straightforward
determination of library composition in various conditions.

The utility of this

technique has already been seen for Plasmodium liver stage metabolic map
construction, as well as in the identification of a master regulator of T. gondii
bradyzoite differentiation (58, 176).
There are still a lot of unanswered questions in apicomplexan differentiation.
With the techniques that are now available together with unprecedented access to a
wealth of “-omics” data, a lot of those questions are ready to be answered.

1.11: Summary of our approach
We have applied a systemic chemical genomics approach to understand the
regulation of C. parvum differentiation. Using a stage specific differentiation assay, we
screened a library of more than 10,000 compounds and identified compounds that
specifically inhibit the sexual differentiation or maturation of C. parvum. The
transcriptomic responses of the parasites to these sexual stage specific inhibitors were
then determined using mRNA-seq. To our knowledge, this is the first time a chemical
genomic approach has been used to study the process of differentiation in
apicomplexans. Our data greatly complement the already published transcriptomics
data available on Cryptosporidium life cycle progression. By robustly comparing our
dataset with already published datasets of Cryptosporidium differentiation and other
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apicomplexans, as well as analyzing the already known mode of actions of several
sexual stage specific inhibitors, we have put forward several hypotheses regarding
potential master regulatory elements and metabolic alteration of Cryptosporidium in the
course of sexual differentiation. Our data highlight the potential commonalities of
Cryptosporidium and other apicomplexans in driving differentiation, as well as
suggesting

some

unique

aspects
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of

Cryptosporidum

biology.

Figure 1: Plasmodium life cycle.

See section 1.4 for detailed description. The illustration is a public domain image by
“CDC - DPDx/ Alexander J. da Silva, PhD; Melanie Moser” and downloaded from
Public Health Image Library (PHIL)
.
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Figure 2: Toxoplasma gondii life cycle.

See section 1.5 for detailed description. The illustration is a public domain image by
“CDC - DPDx/ Alexander J. da Silva, PhD; Melanie Moser” and downloaded from
Public Health Image Library (PHIL).
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Figure 3: Cryptosporidium life cycle.

See section 1.6 for detailed description. The illustration is a public domain image by
“CDC - DPDx/ Alexander J. da Silva, PhD; Melanie Moser” and downloaded from
Public Health Image Library (PHIL).
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Figure 4: Eimeria life cycle.

See section 1.7 for detailed description.

The illustration is licensed under “CNX

OpenStax / CC BY (https://creativecommons.org/licenses/by/4.0)” and is downloaded
from https://commons.wikimedia.org.
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Figure 5: Babesia life cycle.

See section 1.8 for detailed description. The illustration is a public domain image and is
downloaded from cdc.gov.
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CHAPTER 2: A CHEMICAL GENETICS APPROACH TO UNDERSTAND
THE REGULATION OF CRYPTOSPORIDIUM SEXUAL DIFFERENTIATION

2.1: Abstract
Cryptosporidium is an intracellular protozoan parasite that is a leading cause of
childhood diarrhea in Africa and Southeast Asia. It is a member of eukaryotic phylum
Apicomplexa, a group of intracellular parasites that replicate both sexually and
asexually in the course of their life cycle. Sexual differentiation of C. parvum is
required for host to host transmission of the parasite as well as for autoinfection of the
same host. In this study, we have optimized and utilized an in vitro high content
imaging assay to test compounds for activity against the sexual and asexual stages of
the parasite separately. The tested compounds comprise the ReFRAME library, a drug
repurposing library composed of ~12,000 compounds for which extensive prior
knowledge exists including their putative targets and modes of action. Inhibitors of the
host

cell’s

electron

transport

chain

and

purine

nucleotide

biosynthesis

disproportionately affected the sexual differentiation of C. parvum. To identify the
stage specific genes and pathways as well as the potential key regulators of the sexual
differentiation process,

we used RNA-seq

following treatments

with nine

differentiation inhibitor and found that a number of parasite genes were dysregulated
with multiple compound treatments. Ribosomal protein genes were upregulated with
differentiation inhibitor treatments, which suggests that global repression of protein
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translation is associated with C. parvum sexual differentiation. Analysis of publicly
available RNA-seq datasets of C. parvum and other apicomplexan parasites indicates
that this is a common mode of regulating apicomplexan stage differentiation. Our data
also implicate several apicomplexan AP2 transcription factors as key regulators of C.
parvum sexual differentiation.

2.2: Introduction
Cryptosporidium species are one of the most significant etiologic agents of
childhood diarrhea in developing countries (1). There is an urgent need to develop
novel therapeutics, as current treatment options are inadequate for treating
malnourished children and immunodeficient patients, the two populations most
vulnerable to cryptosporidiosis (2). The parasite is a member of the eukaryotic phylum
Apicomplexa, which is comprised of intracellular protozoan parasites. Malaria and
toxoplasmosis are two other major human diseases caused by apicomplexan parasites.
Cryptosporidium transmits through the fecal-oral route in the form of
environmentally resistant oocysts. In the mammalian gut, the oocysts excyst to release
sporozoites that infect the intestinal epithelial cells (IECs).

Initially, it replicates

asexually where intracellular trophozoites develop into type I meronts that release up to
8 merozoites that can repeat this asexual cycle.

After several rounds of asexual

replication, parasites differentiate into type II meronts (containing 4 merozoites instead
of 8), and merozoites from type II meronts differentiate into gamonts upon infecting
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IECs. Gamonts are of two types: uninucleated macrogamonts (i.e. female gamonts),
and multinucleated microgamonts (i.e. male gamonts). Male gamonts fertilize female
gamonts by infecting a macrogamont-harboring IEC.

Meiotic cell division in the

fertilized gamont produces 4 sporozoites that are subsequently enclosed by an oocyst
wall and released from the host cell. Oocysts either excyst within the same host to
cause autoinfection or are released into the environment with feces (3).
In the laboratory setting, oocysts can be excysted by treating with sodium
taurocholate, and the sporozoites can infect numerous cell lines (4, 5). A widely used
in vitro model of Cryptosporidium infection involves infecting the human colorectal
carcinoma cell line HCT8 with the human pathogen C. parvum. In this system, after
initial asexual replication, the gamonts start to emerge at 36 hours post-infection (hpi)
and they are the predominant parasitic form at 72 hpi (6-8). However, fertilization does
not take place within this system, and parasite replication therefore halts after sexual
differentiation (7). Parasitophorous vacuoles of all life cycle stages of C. parvum can
be stained with Vicia villosa lectin (VVL). Previously, we have also reported a marker
protein for female gamonts, DNA meiotic recombinase 1 (DMC1), that can be
visualized by immunostaining (6). As both male and female gamonts emerge within a
similar temporal window post-infection, we used DMC1 expression as a surrogate for
C. parvum sexual differentiation and developed an assay to test the activity of drug-like
small molecules against sexual stages of the parasite.

Several anticryptosporidial

compounds, initially identified by screening using Vicia villosa lectin staining, showed
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a diverse range of activity against the sexual stage of the parasite (6).
Like C. parvum, all the apicomplexan parasites cyclically differentiate into
distinct forms in the course of their complete life cycle. Each of the stages has its own
signature global gene expression pattern (7, 9-12). Molecular understanding of stage
differentiation could provide an opportunity to develop novel control strategies against
human pathogens. Plasmodium species, the causative agents of malaria, first replicate
in hepatocytes upon infecting humans, then differentiate to infect red blood cells, and
finally differentiate into gametocytes that are taken up by mosquito vectors where
sexual reproduction takes place. Transmission blocking strategies for malaria therefore
include inhibiting sexual differentiation of Plasmodium, whereas inhibiting the liver
stage development or its differentiation into the blood-stage would be useful strategies
for malaria prophylaxis (13, 14).

Fast replicating Toxoplasma gondii tachyzoites

differentiate into slowly replicating bradyzoites and form tissue cysts in response to
immune activation in mammalian hosts that can be reactivated upon immune
suppression.

Intervening with this reversible differentiation could lead to better

management of toxoplasmosis (15). C. parvum is different from Plasmodium and
Toxoplasma in the sense that it can complete its whole life cycle within a single
mammalian host where its sexual differentiation is believed to be an obligatory step (as
opposed to the facultative gametocytogenesis observed for P. falciparum where only a
small subset of total parasites actually differentiate into gametocytes).

Therefore,

inhibiting Cryptosporidium sexual differentiation may be a good therapeutic strategy
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(8).
Apicomplexan

stage

differentiation

has

been

studied

with

several

complementary experimental approaches. Comparative “-omics” analyses between life
cycle stages are useful in identifying stage-specific genes and pathways (16-19).
Genetic manipulations, either through forward genetic screens or through targeted
manipulation of key regulators of differentiation, have also been used to study the
regulation of apicomplexan life cycle progression (20-24). Finally, chemical biology
approaches have identified numerous tool compounds to study specific aspects of
apicomplexan biology (25).
In this study, we have used a chemical genetics approach in combination with
mRNA-seq to better understand the regulation of C. parvum sexual differentiation. We
optimized a high content microscopy screening assay based on DMC1 expression, and
screened the ReFRAME (Repurposing, Focused Rescue, and Accelerated Medchem)
chemical library (26) in order to identify compounds that affect C. parvum sexual
differentiation. The ReFRAME library is a library of ~12,000 compounds with high
potential for drug repurposing, and, since the mechanism of action of many ReFRAME
library compounds is known, we reasoned that this approach would enable us to gain
mechanistic insights into C. parvum sexual differentiation. We then followed screening
hit confirmation with mRNA-seq experiments in the presence or absence of selected
differentiation inhibitors. Our results indicate that transcriptional repression of proteins
involved in ribosome biogenesis is necessary for C. parvum sexual differentiation.
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2.3: Results
2.3.1: Optimizing the Identification of Sexually Differentiated C. parvum
Immunostaining DMC1 protein was used to identify sexually differentiated C.
parvum. In order to maximize the sexual differentiation of the parasite and optimize
the identification of DMC1 expressing (DMC1+) parasites in the HCT8 cell infection
model, we made several modifications to our standard culture, staining, and image
analysis methods. Key changes included supplementing the media with 1% serum
instead of 10% serum, addition of the antifungal compound Amphotericin B, using 1%
BSA instead of 4% BSA as blocking solution during immunostaining, and creating an
image mask for all the parasites in the culture (identified by VVL staining) before
locating high DMC1 signal during automated parasite counting.

In the end, we

managed to obtain a good signal-to-noise ratio for the DMC1+ parasites at 72 hours
post infection (hpi) (Figure 1A). The Z’ score, an indicator of assay quality (27), was
consistently > 0.7 for the identification of DMC1+ parasites when using “no primary
antibody” staining as our negative control.
The DMC1+ parasite ratio detected with this method at 48 hpi was almost zero
when using a 0.45 NA objective as is needed for screening with our automated
microscope (Figure 1B). We note that other studies reported a higher proportion of
female gamonts at 48 hpi when detected using other methods (7, 8), and, in our
previous study, we also detected a higher proportion of DMC1+ parasites at 48hpi when
visualized through an objective with more resolving power (6). The ratio of sexual
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stage parasites to total parasites that we detected with the current method at 72 hpi was
very similar to all the prior reports (6-8). This indicated that DMC1 needs to be highly
expressed to be detected by our screening method, suggesting that it detects only
relatively mature female gamonts.
For compound library screening, we devised a strategy in which we tested each
compound in three separate conditions and considered four separate readouts (two
asexual growth readouts and two sexual stage specific) (Figure 1C). The asexual stage
specific readouts were calculated by counting the total number of parasites at 48 and 72
hpi following the addition of compounds at 3 hpi. The number of parasites was
expressed as a ratio to the number of host cell nuclei to control for host cell
cytotoxicity, and the effect of compounds on parasite growth was calculated as percent
inhibition relative to vehicle control-treated wells on each assay plate. The sexual stage
specific conditions and readouts were as follows: 1) addition of compound at 3 hpi and
determination of the ratio of DMC1+ parasites at 72 hpi; and 2) addition of compound
at 48 hpi (when very few DMC1+ parasites are detectable) with the determination of the
ratio of DMC1+ parasites at 72 hpi. We reasoned that compound addition at 3 hpi
would allow us to identify compounds that inhibit sexual differentiation but minimally
impact asexual replication. Note that this readout identified compounds that affect the
commitment to differentiate with minimal effect on asexual growth, but for compounds
that inhibit asexual growth, it yielded little useful information about differentiation due
to low parasite numbers. The second sexual stage specific readout with compound
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addition at 48 hpi addressed this, since it identified compounds that inhibit the
development of female gamonts following the commitment to differentiate
independently of the compound’s effect on asexual growth.
2.3.2: Screening and Validation of the ReFRAME Library
Using the combined stage specific assay strategy, we screened the ReFRAME
compound library at 2 µM concentration. We had multiple DMSO control wells in
each plate as well as two wells of known inhibitor control nitazoxanide.

Each

compound’s activity for each readout was determined by normalizing the parasite
counts with that of the DMSO wells from the same plate. In the end, we determined
the average activity and the standard deviation for all the compounds in the library in
each readout and compounds showing activity two standard deviations above or below
the library mean were denoted as hits in each readout (Figure 1D and 1E). For initial
follow up on compounds meeting this hit definition for at least two of the four
screening readouts, we used resupplied compounds to conduct eight-point dose
response assays, ranging from 50 nM to 10 µM for each assay readout (a total of 311
compounds).
The compounds roughly fit into seven different categories based on the dose
response curves (Figure 2A). 42 compounds showed inhibitory activity in all four
readouts with similar potency. These were denoted as pan-inhibitors, and were felt to
be the most straightforward drug-like compounds for the potential treatment of
cryptosporidiosis (Figure 2B). 70 compounds showed no dose-dependent activity in
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any of the readouts and were considered false positives from the screening (Figure 2C).
All the other compounds were differentially potent among the readouts and together
they constitute a diverse set of tool compounds for studying the C. parvum life cycle.
The most common theme (accounting for 102 compounds) was similar potency for
inhibition of all readouts except for inhibition of DMC1+ parasites upon addition at 48
hpi (Sexual Readout 1 in Figure 1C).

These compounds were either completely

inactive in this readout (Figure 2D) or showed dose dependent activity that failed to
reach complete inhibition at the highest tested concentration (Figure 2E).

We

categorized these compounds as asexual inhibitors. On the other hand, 23 compounds
were highly potent against the sexual stage when added at 3 hpi, but had little effect in
the other conditions/readouts (Figure 2F).

These compounds were categorized as

differentiation inhibitors and were the predominant focus of our follow up experiments.
A further 9 compounds showed a narrow but discernable specificity also in the sexual
differentiation readout (Figure 2G).

19 compounds induced sexual differentiation

(Figure 2H) or sexual development (Figure 2I) or both (Figure 2J) at concentrations
that were not inhibitory to asexual stages in a dose dependent manner. We did not
classify 46 compounds in any of the above-mentioned categories mainly because they
were not tested in all conditions or their dose response curves seemed to be in the
exponential phase and did not reach the above 80% inhibition threshold at the highest
concentration tested (Figure 2K). Interestingly, a particular differentiation inducer, the
Endothelin A receptor agonist S-1255, highly induced the expression of DMC1 at 48
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hpi, which was unique among all the compounds that we tested (Figure 2L).
Supplementary Table 1 contains the SMILES structures of all compounds tested in
follow up, their putative targets and how they were categorized. Supplementary Figure
1 contains their dose response curves for each assay readout.
2.3.3: Several Differentiation Inhibitors Share Common Modes of Action and
Activity Kinetics
The compounds categorized as differentiation inhibitors completely inhibited
the emergence of DMC1+ parasites in a dose dependent manner. However, they did not
completely inhibit asexual parasite growth at any concentration tested (Figure 2F). All
23 of them had minimal or no effect on DMC1 expression when added at 48 hpi,
suggesting that they worked by inhibiting early steps in the differentiation pathway.
Interestingly, four of them were mitochondrial electron transport chain inhibitors
(Figure 3A), five of them were inhibitors of nucleotide biosynthesis (Figure 3A, 3B),
and two of them were fumagillin analogs that covalently inhibit methionine
aminopeptidase 2 (Figure 3A). Interestingly, the confirmed asexual stage inhibitors
also included compounds that inhibit nucleotide biosynthesis, but the putative targets of
differentiation inhibitors were exclusively involved in the synthesis of purine
nucleotides (Figure 3B).
We decided to further probe the mechanisms underlying C. parvum sexual
differentiation using several of these tool compounds.

We purchased seven

differentiation inhibitors from independent sources and two were resupplied from the

109

ReFRAME library (Figure 3A). These nine compounds were selected because they
showed a highly selective inhibitory activity against sexual differentiation for a wide
range of concentration. We first tested a broader range of concentrations for each for
the condition 2 readouts, which reconfirmed the initial dose dependent characterization
for all nine compounds (Figure 3C).
Previous experiments looking at C. parvum life cycle stages at different time
points post infection suggest that sexual differentiation takes place between 36 and 48
hpi (7, 8). This view is consistent with our observation that all the differentiation
inhibitors were highly efficacious in inhibiting sexual differentiation when added 3 hpi,
but ineffective to do so when added 48hpi. While this roughly indicates that they need
to be added before the differentiation takes place, we wanted to test this phenomenon
with a higher temporal resolution. To probe if there is a temporal window when the
differentiation inhibitors need to be present to exert their effect, we added the nine
retested differentiation inhibitors at 3, 12, 24, 34 or 48 hpi, and determined the ratio of
DMC1+ parasites at 72 hpi (Figure 4A). Six compounds showed highly efficacious
dose dependent activity when added up to 34 hpi. On the other hand, three compounds
(i.e. pralatrexate, mycophenolate, and TVB-2640) lost that activity if added at or after
24 hpi (Figure 4B), suggesting that prolonged exposure was required and/or that they
affect early stages of differentiation such as commitment. Nitazoxanide, which was
classified as a pan-inhibitor, had the same effect regardless of the timing of addition.
This was consistent with the likelihood that pan inhibitors have a general toxic effect on
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C. parvum growth that is independent of the stage of the parasite’s life cycle.
2.3.4: mRNA-seq Analysis of Compound Effects on Gene Expression
To gain insights into the genetic regulation of Cryptosporidium sexual
differentiation, we examined the effects of selected differentiation inhibitors on parasite
and host gene expression using mRNA-seq and the C. parvum HCT8 cell culture
system. A suitable time point was first determined by conducting mRNA-seq in the
absence of differentiation inhibitors at 18, 36, 48, and 72 hpi.

We aligned the

sequencing reads with both human and C. parvum genomes using HISAT2 (28),
created separate subsets of alignment files uniquely aligned to the parasite or host
genome, counted the number of alignments per gene using HTseq (29), and finally
performed differential gene expression analysis using DEseq2 (30). Genes with ≥ 2fold expression difference at a 10% false discovery rate (FDR) were considered as
differentially regulated. Overall, very few parasite genes were differentially regulated
between the 18 and 36 hpi samples, but a large number of genes were differentially
regulated between the 36 and 48 hpi samples and the 48 and 72 hpi samples. On the
other hand, a relatively small number of host genes were differentially expressed
(Figure 5A). Given these data, we selected the 48 hpi timepoint for the transcriptomic
analysis of the differentiation inhibitor treatments in subsequent experiments. Each
compound was used at a dose that was previously found to be highly selective for
sexual differentiation (see Figure 3C), and mRNA-seq libraries were prepared at 48 hpi
after each of the compounds or vehicle were added at 3 hpi (Figure 5B)(2 biological
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replicates each, except for pralatrexate (n=1) for which library preparation failed for
one replicate).)
Compound treatment affected both host and parasite gene expression (Figure
5B).

The two methionine aminopeptidase2 inhibitors, AGM-1470 and Beloranib

hemioxalate, very selectively dysregulated parasite gene expression, whereas the
inhibitors of oxidative phosphorylation and mubritinib dysregulated a high number of
host genes. We also performed the differentiatial gene expression analysis using the
the combined expression count files of the host and the parasite genes together, which
also confirmed the predominantly parasite-specific dysregulation of genes by the
MetAP2 inhibitor AGM-1470 (Supplementary figure 2).

Note that in these

experiments the proportion of infected and uninfected host cells varied with time point
and compound treatments, which complicated comparative analysis of host gene
expression.

We have therefore not performed any detailed analysis on host gene

expression beyond determining the number of affected genes in the host transcriptome.
There was a high degree of identity between genes that were dysregulated by
the various differentiation inhibitor treatments (Figure 5C, 5D). Supplementary Table
2 contains the fold changes of parasite genes that met the threshold of statistical cutoff
(FDR <0.1).

As the nine differentiation inhibitors act upon eight different target

proteins, the uniquely dysregulated genes are highly likely to be compound specific
effects. In contrast, as all our nine tested compounds causes the same effect of sexual
differentiatiaon inhibition, commonly dysregulated genes by multiple treatments might
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be more involved in regulating the sexual differentiation. In line with this reasoning,
we compiled a list of parasite genes that were dysregulated with the majority (at least
five or more) of the compound treatments. We compared this gene list with the list of
significantly dysregulated genes identified through RNA-seq between C. parvum
asexual and female stage parasites separated by flow cytometry.

Our commonly

upregulated gene set was highly similar to the gene set overexpressed in the asexual
stage compared to female stage and our commonly downregulated gene set had a high
degree of similarity with the genes overexpressed in the female parasites
(Supplementary figure 3), which validates our dataset and our approach of selecting
stage-specific genes.
2.3.5: Female-specific Genes are Down-regulated and Asexual Stage-specific
Genes are Upregulated Following Treatment with Differentiation Inhibitors
Life cycle stage specific gene expression is a well-documented phenomenon in
apicomplexan parasites.

We wanted to check if the dysregulated genes from the

compound treated samples were stage specific or not. To putatively identify stage
specific genes, we have used two relevant RNA-seq datasets available in the EUpathdb
database (31), one for C. parvum and the other one for Plasmodium. The Plasmodium
dataset compared gene expression patterns between the asexual blood stage, and male
and female gametocytes (18). We selected Plasmodium genes that are differentially
expressed between these stages (FDR<0.1; log2 fold change of ≥1). Genes that are
upregulated in the asexual stage compared to gametocytes were denoted as asexual
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stage specific genes. Genes that are upregulated in both gametocytes or in one of the
gametocytes compared to asexual stage were denoted as gametocyte, male and female
specific genes accordingly.

Ortholog transformation of each of these gene sets

identified their homologs in the C. parvum genome, and was used to enable comparison
of C. parvum and Plasmodium data.

The Eupathdb C. parvum dataset contains the

gene expression pattern for FAC sorted asexual stage parasites and female gamonts (7).
Using the same cutoffs for differential expression, we identified asexual and female
specific genes using this dataset. If any gene was putatively identified as asexual stage
specific or male specific based on the Plasmodium database but marked as female
specific from the C. parvum dataset or vice versa, we denoted them as divergent genes.
All the other genes without any stage specific expression were denoted as unresolved.
This set of genes most likely encode proteins that perform essential functions
throughout the life cycle of C. parvum.
After using these existing datasets to classify all of the C. parvum genes as
above, we checked if there was any stage specificity in the differentially expressed
genes identified following compound treatments. All the compounds showed a similar
pattern in our analysis; asexual stage specific genes were upregulated and female stage
specific genes were downregulated due to compound treatment (Figure 5E,
Supplementary Figure 2). We did not observe any strong effect in the other classes of
genes.
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2.3.6: Proteins Involved in Ribosome Formation are Upregulated in Response to
Differentiation Inhibitors
We performed functional annotation enrichment analysis of the upregulated and
downregulated gene sets following treatment with all of the differentiation inhibitors
using DAVID Bioinformatics Resources 6.8 (32). As there was a high degree of
similarity between gene sets dysregulated by the different compound treatments, the
functional annotation enrichment analysis identified similar gene classes enriched with
all the treatments (Supplementary Table 3). Therefore, to limit the analysis to common
pathways involved in differentiation and exclude potentially misleading effects seen
with individual compounds, we repeated the analysis with gene sets significantly
dysregulated (FDR<0.1) following treatments with the majority of the compounds (five
out of nine treatments).

We noticed that for the genes that were significantly

dysregulated with multiple treatments, the log2 fold-change was often marginally
below 1 for some treatments, so this cutoff likely resulted in the erroneous exclusion of
some biologically relevant differentially expressed genes in the combined gene sets.
Therefore, we bypassed setting a fold change cutoff for selecting commonly
dysregulated genes and selected them only based on the FDR cutoff, which provided a
better representation of all the different compound treatments. Following treatment
with differentiation inhibitors, this analysis indicated that genes encoding proteins
associated with ribosome biogenesis and structure were commonly upregulated,
whereas genes encoding proteins involved with biosynthesis of secondary metabolites
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and glycolysis were commonly downregulated (Figure 6A).
We wanted to check whether the upregulation of ribosomal genes was just a
response to compound treatment or represented biologically relevant differential
expression between C. parvum life cycle stages. For this, we reanalyzed the Eupathdb
C. parvum dataset comparing the female and asexual transcriptomes to determine
whether the functional annotation enrichment analysis of our dataset correlated with
that dataset or not (7). As compound treatment inhibited sexual differentiation, genes
upregulated with compound treatment should be downregulated in female gamonts
when compared with the asexual stage and vice versa. Similarly, genes involved in
glycolysis should be upregulated in female gamonts.

Analysis of the existing C.

parvum dataset confirmed these predictions (Figure 6A). Furthermore, ribosomal genes
were the most significantly downregulated gene class in female gametocytes, strongly
suggesting that modulating ribosome formation could be a key regulatory mechanism
for parasite differentiation.
We plotted the actual average transcript per million (TPM) values of all the
genes that code for proteins that are structural components of the ribosome. This
indicated that mRNAs encoding this class of proteins reached their peak concentration
at 36 hpi and then decrease rapidly at 48 and 72 hpi (Figure 6B). Compound treatment
inhibited the repression of most of the members in this gene set.

Interestingly,

hierarchical clustering of the expression pattern of this gene set clustered the compound
treated samples (prepared from 48 hpi) with 18 hpi and 36 hpi control samples whereas

116

the 48 hpi control sample clustered with 72 hpi control sample (Figure 6B).
Ribosomal protein genes are scattered across the C. parvum genome, yet the
mRNA levels were highly correlated with each other across time points and compound
treatment. This prompted us to search for conserved sequence signatures within the
upstream and downstream regions of these genes. Differential enrichment analysis of
the upstream region of the ribosomal protein genes identified a DNA motif,
BYGTCTC, that was highly enriched in these genes compared to all the annotated
protein coding genes of C. parvum (Figure 6C). Other than the ribosome structural
proteins (n=78), the motif was found in the promoter region of 455 additional genes.
We checked if those genes were consistently upregulated or downregulated
(dysregulated in >=5 compound treatment), and, based on a Chi-square test, the motif
was more commonly found in the promoter region of genes upregulated following
treatment with differentiation inhibitors (Figure 6D). Furthermore, analysis of the
motif’s location indicated that it is typically located closer to the start codon for genes
coding for ribosomal structural proteins and genes that were consistently upregulated,
and is generally distally placed for the genes that were downregulated following
compound treatment (Figure 6E). A comparison of the downstream sequences of
ribosomal genes with other C. parvum genes did not identify significantly enriched
sequence motifs.
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2.3.7: Ribosomal Proteins are Generally Downregulated in Response to
Translational Repression Programs During Differentiation in Apicomplexan
Parasites
Our mRNA-seq dataset indicated that ribosomal protein genes are
downregulated during C. parvum sexual differentiation.

We checked if this is a

common mechanism of regulating differentiation in apicomplexan parasites by using a
variety of datasets available via Eupathdb to identify genes that are upregulated or
downregulated in different life cycle stages of other apicomplexan parasites
(Supplementary Table 4) (11, 18, 33-36).

In Plasmodium, ribosomal genes are

downregulated during female gametocytogenesis as well as in salivary gland
sporozoites compared to midgut oocysts.

In T. gondii, ribosomal genes are

downregulated in bradyzoites compared to tachyzoites (Figure 6F). Interestingly, in all
the three above mentioned differentiation axes, mechanistic studies indicate that post
transcriptional repression of gene expression plays a critical role in the differentiation
process. During maturation of P. berghei female gametocytes, overexpressed mRNAs
are protected at the cytoplasmic P bodies, which also repress their translation (37, 38).
In Plasmodium salivary gland sporozoites, inhibitory phosphorylation of eukaryotic
translation initiation factor alpha (eIF2α) represses the translation of mRNAs (39). The
T. gondii eIF2α is also observed to be phosphorylated in bradyzoites (40, 41).
Collectively, these publications indicate that the repression of ribosomal proteins
correlates with a translational repression program in Plasmodium and Toxoplasma. In
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Eimeria, ribosomal genes are upregulated in merozoites compared to both sporozoites
(the earlier stage) and gametocytes (later stages) (Figure 6F). Overall, in all the three
apicomplexan parasites where sexual and asexual stage gene expression has been
compared with RNA-seq, ribosomal proteins are enriched in gene sets that are
downregulated in sexual stages.
2.3.8: The DNA Recognition Motif of Four ApiAp2 Transcription Factors is
Significantly Enriched in the Promoter Regions of Commonly Downregulated
Genes
Genes that are commonly downregulated with five or more differentiation
inhibitor treatments are potentially overexpressed during or after sexual differentiation.
Specific regulatory DNA sequences might control their sexual stage specific expression
pattern. To identify such potential regulatory elements, we screened the promoter
regions of these genes for significant enrichment of DNA motifs. We found that the
motif “CATGCAWH” is the most significantly enriched DNA motif in the promoter
region of these genes (Figure 7B).
The family of apicomplexan AP2 transcription factors (TFs) has been
extensively studied in Plasmodium parasites and several of them have been implicated
in regulating parasite differentiation in the course of its life cycle (21, 22). There are 18
putative ApiAP2 TFs in the C. parvum genome based on sequence similarity to the
AP2 DNA binding domain (42).

Previously, using DNA binding microarray, the

putative DNA recognition motifs of several C. parvum AP2 TFs were identified (42).
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Interestingly, the “CATGCAWH” motif that is significantly enriched in the promoters
of our downregulated gene set bears a high degree of similarity to the recognition site
of four different ApiAP2 TFs (listed in Figure 7A). Two of these TFs (cgd8_3230 and
cgd2_3490) themselves are also significantly dysregulated by five or more
differentiation inhibitor treatments (Figure 7A), which suggests that they might play
key regulatory roles in controlling the expression of sexual stage specific genes in C.
parvum.
2.4: Discussion
In this study, we have tested the ReFRAME library, a diverse set of biologically
active compounds, for activity against the sexual and asexual phases of the C. parvum
life cycle. We identified compounds with differing modes of activity against the two
life cycle stages and performed detailed transcriptomic analyses of a set of compounds
that selectively affect the parasite sexual differentiation. We identified that proteins
involved in ribosome formation are transcriptionally downregulated as parasites
differentiate into sexual stage and treatment with differentiation inhibitors negatively
affects this mode of regulation. In addition, we found that an experimentally validated
binding site of several C. parvum ApiAP2 TFs is significantly enriched in the promoter
region of genes that are downregulated with multiple differentiation inhibitor
treatments, which indicates that these TFs play key regulatory roles in C. parvum
sexual differentiation.
The compounds in the ReFRAME library were initially developed to treat a
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variety of diseases, with a bias towards cancer therapeutics.

Respiratory,

cardiovascular, and CNS conditions are also highly featured amongst the disease
indications; altogether these indications account for ~86% of ReFRAME compounds,
which were primarily developed to treat human conditions not caused by infectious
agents (26). Therefore, many ReFRAME compounds target human proteins or RNAs.
As an intracellular parasite, C. parvum must be sensitive to the altered condition in the
host cells. It is therefore highly likely that a lot of validated hits from our screen are
acting on C. parvum by altering the host cell condition, without directly targeting
parasite proteins. A prime example of such mode of action is the four identified
compounds that likely inhibit parasite sexual differentiation by acting on mitochondrial
function (Figure 3A). C. parvum does not contain a fully functional mitochondrion
itself; instead, it harbors a relict mitochondrion without a genome that is termed a
mitosome (43). Consistent with a primary effect on the host cell, the two of the
mitochondrial inhibitors included in our RNA-seq analysis caused dysregulation of a
high number of host genes in addition to parasite genes (Figure 5B). This strongly
suggests that host cell mitochondrial function is critical for parasite life cycle
progression and its dysregulation affects the parasite sexual differentiation more
profoundly than general growth. Interestingly, media removal to the establish an airliquid-interface (ALI) condition during the culture of stem cell derived mouse intestinal
epithelial cells supports the continuous cultivation of C. parvum in vitro (44). Parasite
vacuole number significantly increases under the ALI condition from two days onwards
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post infection compared to non-ALI condition, and, in contrast to the HCT8 culture
system, both fertilization and production of infectious oocysts occurs. Consistent with
our finding that inhibitors of the host cell mitochondrian block C. parvum sexual
development, host cell RNA-seq comparison of the ALI and non-ALI conditions
identified oxidative phosphorylation as the most significantly upregulated pathway
under ALI conditions (44).
Targets of five differentiation inhibitors are enzymes of interconnected folate
metabolism and purine nucleotide biosynthetic pathways (Figure 3A, 3B). We persued
two of these in our follow up experiments, pralatrexate, an inhibitor of mammalian
dihydrofolate reductase (DHFR) (45), and mycophenolate mofetil, a prodrug that is
converted into mycophenolic acid, which inhibits host inosine-5'-monophosphate
dehydrogenase (IMPDH) (46). Recently, it has been shown that knocking out several
of the C. parvum proteins involved in nucleotide salvage, including DHFR-TS
(cgd4_4460) and IMPDH (cgd6_20), has no effect on the replication of C. parvum
(tested for 48 hpi) (47). However, unlike WT parasites, these mutants are susceptible
to pharmacological inhibition of relevant host nucleotide synthesis. Interestingly, both
of these enzymes are significantly upregulated at 72 hpi compared to 48 hpi in vehicle
treated C. parvum infection, which suggests an increased need for nucleotides during
the parasite sexual stage (Supplementary Table 2). Phenotypes of nucleotide salvage
pathway knockout mutants of C. parvum suggest that the parasite has redundant
pathways to synthesize pyrimidine nucleotides but not purine nucleotides, which makes
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them comparatively more dependent on the host for purines. As a likely cause of this
duplicity, it has been proposed that host derived purine nucleotides are directly
imported as ATP that fulfills the energy demand of the parasites in addition to serving
as nucleic acid building blocks (47). As discussed later, our data suggest that in the
sexual stage, either energy demand is more or access to the host nucleotide pool is
reduced compared to asexual C. parvum. This might be the reason why the sexual
stages of the parasite are disproportionally affected by inhibitors of host purine
biosynthesis compared to asexual stages. Interestingly, both of the retested nucleotide
biosynthesis inhibitors affected sexual differentiation only when added at 3hpi and
12hpi, but failed to completely do so when added later (Figure 4B). Perhaps the host
ATP pool is sufficiently depleted for inhibition of sexual differentiation only with
prolonged exposure of these compounds.
AGM 1470 and beloranib are fumagillin analogs that covalently bind to human
methionine aminopeptidase 2 (MetAP2) (48). MetAP2 is a bifunctional protein and
one of its functions is to remove the N-terminal methionine from nascent proteins.
Fumagillin analogs covalently bind to a histidine residue in the active site of MetAP2
and block this function (48). The active site histidine and the surrounding residues are
conserved in C. parvum MetAP2. The other function of MetAP2 is to bind and protect
the eukaryotic translation initiation factor 2 alpha (eIF2α) from inhibitory
phosphorylation (49). eIF2α plays a critical role in the rate-limiting step of translation
initiation, and the phosphorylation of eIF2α inhibits this activity (50). Several kinases
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phosphorylate eIF2α in response to diverse types of stresses (51). Covalent binding of
the fumagillin analogs does not directly alter this second function of MetAP2; however,
they can indirectly enhance this function as the covalent modification of the protein
enhances its stability (52, 53).

Treatment with these compounds significantly

dysregulated a high number of parasite genes, but, compared to the other differentiation
inhibitors, a very small number of host cell genes (Figure 5B). Therefore, while we
cannot formally reject the possibility that these fumagillin analogs affect C. parvum
through effects on host metAP2, it is highly likely that their effect on parasite sexual
differentiation results from inhibiting the parasite enzyme.
Consistent with this possibility, regulation of eIF2α phosphorylation is
implicated in controlling stage differentiation in both Plasmodium and Toxoplasma. T.
gondii eIF2α phosphorylation is necessary for tachyzoite to bradyzoite differentiation
(40, 41, 54-56).

In Plasmodium, several proteins required for the liver stage are

actually transcribed in salivary gland sporozoites, but their translation is repressed (19,
57, 58). IK2, a kinase of eIF2α, is critical for this translational silencing (39, 59). Even
though MetAP2 has been implicated in the protection of eIF2α, its role has never been
specifically investigated in apicomplexan eIF2α phosphorylation regulation of stage
differentiation. As MetAP2 inhibitors inhibit the sexual differentiation of C. parvum
and the transcriptional signature of this differentiation inhibition mimics translational
silencing in apicomplexan parasites (Figure 6F), it is likely that these fumagillin
analogs inhibit C. parvum sexual differentiation by inhibiting parasite eIF2α
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phosphorylation (Figure 8).

In this model, normal sexual differentiation requires

phosphorylation of parasite eIF2α, which turns on a translational silencing program in
the parasites. AGM 1470 and beloranib bind and stabilize parasite MetAP2, which
leads to increased protection of eIF2α from inhibitory phosphorylation. As a result, the
translational silencing program fails to activate and sexual differentiation is inhibited.
Among the compounds that induced sexual differentiation or development,
common putative targets include DNA topoisomerase (four compounds), cyclin
dependent kinases (cdks, three compounds), and Aurora kinases (two compounds).
And among other validated hits, two cdk inhibitors are classified as pan-inhibitors and
two others as asexual inhibitors. Similarly, five putative topoisomerase inhibitors and
two aurora kinase inhibitors are classified as asexual stage specific inhibitors
(Supplementary Table 1).
The purpose of the RNA-seq experiments reported here was to identify sexual
and asexual stage specific genes and pathways, some of which might be involved in
regulating C. parvum sexual differentiation. We selected compounds with diverse
structures and putative targets for this study, all of which cause the same effect, i.e.
inhibition of sexual differentiation (Figure 3A).

For each of the compounds, we

selected a dose that highly and preferentially inhibits differentiation (Figure 3B). We
reasoned that with such a high effective dose for a particular phenotype, dysregulated
genes and pathways common in the majority of the treatments would be parasite life
cycle stage specific elements, as opposed to compound specific dysregulated elements.
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Indeed, there was a high degree of commonality in dysregulated genes (Figure 5C and
5D, supplementary table 2). According to our experimental design, asexual stage
specific genes should be upregulated and sexual stage specific genes should be
downregulated following treatment with the differentiation inhibitors. We compared
the consistency of our approach with the previously published complementary approach
of conducting RNA-seq on FAC sorted parasites using a female gamont-specific
promoter driven reporter to separate asexual and female sexual stage specific parasites
(7).

To include the male stage specific gene expression in our comparison, we

interpolated stage specificity of C. parvum genes from a similar FAC sorting-based
dataset of Plasmodium (18). A high degree of correlation between our dataset and the
two other datasets validates our approach (Figure 5E). At the same time, it also
indicates that the sexual stage specific gene expression pattern is reasonably conserved
between Plasmodium and Cryptosporidium.
Functional annotation enrichment analysis of commonly dysregulated genes
identified (dysregulated in ≥5 compound treatments) glycolysis as the most highly
enriched pathway in the downregulated gene set and ribosome biogenesis in the
upregulated gene sets (Figure 6A, Supplementary Table 3). The result of this analysis
is consistent with the same analysis performed for dysregulated gene sets between
asexual and female gamonts (Figure 6B).

In the absence of a fully functional

mitochondrion, glycolysis is considered to be the main energy generating pathway for
C. parvum. As our data indicate that this pathway is more active following sexual
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differentiation, we propose two mutually non-exclusive models to explain this stage
specific energy metabolism in C. parvum. One is that the energy demand in sexually
differentiated parasites is simply higher compared to the asexual stages. That can arise
from the necessity of producing residual bodies, a type of energy storage structure
composed of carbohydrates and other metabolites that are observed in both
macrogamonts and oocysts (60, 61). Another possibility is that the sexual stages are
less efficient in importing energy equivalents from the host, which is compensated by
increased energy production by the parasite itself. As mentioned above, it has been
proposed that C. parvum might harbor transporters that directly take up ATP from the
host cell (47). Stage specific differences in the abundance of such a transporter might
reduce energy uptake from the host cell following sexual differentiation. Overall, each
model is consistent with our observations that inhibition of host oxidative
phosphorylation and purine biosynthesis both affect sexual differentiation.
The upregulation of ribosome biogenesis and structural proteins following
differentiation inhibitor treatments suggests an overall lower rate of protein synthesis in
sexually differentiated parasites (Figure 6A and 6B). This persuaded us to look for
similar transcriptional dysregulation patterns in other apicomplexans, as translational
repression is a well-documented mechanism of regulating stage differentiation in
apicomplexans. In all three differentiation axes where translational silencing has been
validated with genetic experiments, the same ribosomal dysregulation signature has
been observed (Figure 6F). Collectively, this strongly associates the downregulation of
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ribosomal genes in RNA-seq datasets with the establishment of a translational silencing
program.

Without further experimental validation, however, it is unclear if the

downregulation of ribosomal genes is causative for translational silencing or if the
establishment of translational silencing somehow causes the transcriptional
downregulation of ribosomal genes. Downregulation of ribosomal proteins is also
observed in Eimeria gametocytogenesis; however, no mechanistic experiment to
determine the regulation of this differentiation has been published.
One important point to note here is that all the apicomplexan parasites
obviously possess stage specific proteins that are overexpressed under these general
transcriptionally silenced and impaired-ribosome-biogenesis conditions.

How the

expression of those proteins is enhanced under such a condition is an important
research question. Perhaps the answer is contained in the fact that ribosomes are not
homogenous structures that keep translating all the mRNAs at a constant rate. Rather,
they are heterogeneous structures that vary in building blocks between cell types and
conditions, and they can selectively translate certain mRNAs over others (62). It would
be interesting to experimentally test if such “special ribosomes” play a key regulatory
role in apicomplexan stage differentiation.
Differential enrichment of mRNAs between conditions can result from their
altered transcription or stability. In our RNA-seq follow up analysis, we focused on
transcriptional regulation by looking at the putative promoter regions of C. parvum
genes. We searched for enriched sequence motifs in the promoter region on various
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subsets of C. parvum genes that are connected by similar dysregulation patterns and/or
are from the same pathway or protein class. We identified very significant enrichment
of a DNA motif in the upstream region of the ribosomal structure genes (figure 6C).
This suggests that their transcription is controlled by the same transcriptional regulators
and putatively explains why these genes are dysregulated as a group (Figure 6B). The
other significant promoter motif signal that we observed came from the genes that are
downregulated in ≥5 compounds treatments (Figure 7B). Interestingly, a part of this
motif is identical to the experimentally validated core binding site of four different
ApiAP2 transcription factors. TFs of this class are well defined as key regulators of
apicomplexan stage differentiation. In both Plasmodium and Toxoplasma, the binding
sites of multiple AP2 TFs are similar. They often function antagonistically to each
other and the expression levels of the genes that they regulate are essentially
determined by the expression levels of the TFs (63-65). Among the four C. parvum
AP2 TFS that bind to the “TGCAT” core, cgd8_3230 is significantly upregulated in six
treatments whereas cgd2_3490 is significantly downregulated with eight different
treatments (Figure 7B). Combining all this information, we propose that the expression
of a set of sexual stage specific genes is activated by cgd2_3490 and repressed by
cgd8_3230.
Among all the validated hits from our screening, we have only used the
differentiation inhibitors in this study to better understand the genetic regulation of
sexual differentiation of C. parvum. Adding the other classes of hits, specifically the
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sexual differentiation and development inducers, into the mRNA-seq analysis pipeline
may further assist in recognizing the key regulatory factors in parasite sexual
differentiation. Moreover, there are still numerous open questions about the parasite
life cycle. The different classes of compounds identified in this study can be utilized in
diverse ways to answer some of those questions. For example, in an animal model or in
a continuous in vitro culture system, differentiation inhibitors can be used to check if
sexual differentiation is an obligatory step following several rounds of asexual
replication, i.e. whether the parasite would die or continue to grow asexually with a
blockade in sexual differentiation. Such an experimental design would address the
druggability potential of C. parvum sexual differentiation and may also lead to the
identification of tool compounds to facilitate continuous cultivation of C. parvum in a
simpler culture system than is currently available.
Before concluding, we would like to mention that as the ReFRAME library is
biased towards human protein targets, applying a similar screening methodology with a
less biased library might identify compounds that would more specifically target C.
parvum proteins. Additionally, other phenotypic patterns may potentially be caused by
compound treatment that we have not yet captured. For example, we have not yet
identified a selective sexual development inhibitor or a sexual stage specific inhibitor
that would inhibit both sexual differentiation and development. The utility of such tool
compounds would be immense for the mechanistic understanding of C. parvum sexual
differentiation.
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2.5: Material and Methods
2.5.1: In vitro C. parvum Infection Model
Human ileocecal adenocarcinoma (HCT-8) cells (ATCC; catalog# CCL-244)
were used as host cells for C. parvum infection. The cells were passaged in modified
RPMI-1640 medium (Gibco, catalog# A10491–01) supplemented with 10% heat
inactivated fetal bovine serum (Sigma) and antibiotic solution (120U/mL penicillin and
120 ug/ml streptomycin; Gibco 15140-122). Cell culture passage number 9 to 36 were
used for parasite infection.

C. parvum oocysts were routinely purchased from

Bunchgrass Farm (Deary, ID) and used for up to 6 months. To infect HCT8 cells,
oocysts were excysted in vitro by treating them first with 10mM HCL (37C, 10
minutes) and then 2mM sodium taurocholate (16C, 10 minutes; Sigma T4009). Host
cells are grown to 90% confluency in appropriate plates for infection. Infection media
was same as HCT8 culture media except that it was supplemented with 1% serum
instead of 10% and antifungal compound Amphotericin B (0.625 ug/ml; Sigma A2942)
was added in addition to the antibiotic solution. Infected cells are incubated at 37C
with 5% CO2.
2.5.2: Compound Screening and Dose Response Validation
Host cells were grown in 384 well plates and infected with 5500 oocysts per
well. Following infection, compounds were added at appropriate timepoints using
Biotek Precision microplate pipetting system.

Cultures were washed with wash

solution (0.1% tween 20 in 1X PBS) 3 times before fixing with 4% paraformaldehyde
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and permeabilizing with 0.25% triton X-100. 1% BSA was used for blocking before
staining with Anti DMC1 antibody clone 1H10G7 (hybridoma supernatant). Plates
were incubatd at 4c for at-least 24 hours with the primary antibody before washing with
the wash solution three times, with five minutes incubation between each wash.
Subsequently, the culture was stained with 4ug/ml Alexa Fluor 568 goat anti-mouse
IgG (Invitrogen, A-11004) and 1.33 µg/mL FITC-labeled Vicia villosa lectin (Vector
Laboratories, FL-1231) in 1% BSA for at-least 1 h at 37 °C. Finally, 0.09 mM Hoechst
33258 (AnaSpec, catalog# AS-83219) stain was added to stain the nucleus for 10
minutes. Then the wells were washed with wash solution five times, with five minutes
incubation between each wash.
The culture plates were imaged with Nikon Eclipse Ti2000 epifluorescence
microscope equipped with automated stage movement, using an objective with 20X
magnification and 0.45 numerical aperture. 5 by 5 field of views were captured for
each well. Images were analyzed with an automated Imagej macro (66) to count the
number of nucleus, total parasite and DMC1+ parasites.
2.5.3: mRNA-seq Sample Preparation and Sequencing
HCT8 cells were grown to 90% confluence on 24 well plates and infected with
an appropriate number of excysted oocyst (2, 1, 0.5 and 0.4 million for 18, 36, 48 and
72 hpi samples respectively) in 1 mL of infection media. Compound or DMSO was
added at appropriate time points. Before RNA isolation, wells were washed 3 times
with the wash buffer. Total RNA was isolated using the Qiagen RNeasy mini kit (cat
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#74104). Messenger RNA enrichment and sequencing libraries were prepared using
NEXTFLEX Rapid Directional RNA-seq Library Prep kit bundle (cat # NOVA-513810) following the kit manufacturer’s protocol. The next-generation sequencing (75
Base pair single end) was performed in the Vermont Integrative Genomics Resource
Massively Parallel Sequencing Facility and was supported by the University of
Vermont Cancer Center, Lake Champlain Cancer Research Organization, UVM
College of Agriculture and Life Sciences, and the UVM Larner College of Medicine.
2.5.4: mRNA-seq Data Analysis
Sequences were demultiplexed and provided in “.fastq” format by Vermont
Integrative Genomic Resource core facility. The sequences were uploaded to the
public server of the Galaxy web platform (usegalaxy.org) and all the subsequent
analyses were performed in that server (67). Sequences were quality trimmed using
Trimmomatic (68) and then aligned to a combined genome sequence file of Human
genome (Gencode release 31, GRCh38, (69)) and C. parvum genome (Cryptodb release
44, C. parvum IowaII, (70)) using HISAT2 (28). Alignment file was sliced into host
part and parasite part using the Slice tool and processed separately in subsequent
operations. We used HTseq (29) to determine the number of reads aligned to each
gene. Deseq2 was used to analyze differential expression between appropriate samples
(30). Deseq2 result files were downloaded, relevant values of the genes that met the
differential expression cutoff were combined in a Microsoft excel file.
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2.5.5: Pathway Analysis and Gene Expression Heatmap Generation
Functional annotation enrichment analyses with C. parvum genes were
performed in DAVID Bioinformatics Resources 6.8 (32, 71). Appropriate gene ids
were copied as gene list and CRYPTODB_ID was selected as Identifier type. All C.
parvum genes were used as background and all the other options were used as default.
For other apicomplexan parasites, “analyze result” was used from an appropriate
apicomplexan parasite database after selecting appropriate genes using gene id search
(31). TPM values of C. parvum ribosomal proteins were used to generate expression
heatmap as well as clustering of samples using shinyheatmap (72). For clustering, the
Euclidean distance metric and the “complete” linkage algorithm were used.
2.5.6: C. parvum genes’ Upstream and Downstream Sequence Analysis
1 kb upstream and 1 kb downstream region of all the C. parvum genes were
uploaded in the usegalaxy.org server. All the C. parvum coding sequences were then
used as adapter sequences in the cutadapter tool to remove any coding part from the up
and downstream sequences of the C. parvum genes. Such regulatory sequences from
the selected genes were used as inputs and regulatory sequences from all the C. parvum
genes were used as background in the “DREME” tool (73) hosted at “MEME-suite”
server (74) to identify significantly enriched motifs. Position of specific motifs at the
regulatory sequences of C. parvum genes were determined using the “FIMO” tool (75).
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2.6: Figure legends
Figure 1: Stage specific assay development and library screening. A) Two
replicate experiments showing anti-DMC1 antibody staining is sensitive and specific
for quantitative screening purposes. HCT8 cell monolayers grown in 384-well culture
plates were infected with C. parvum, and then stained for the female gamont-specific
marker DMC1 at 72 hours post infection (hpi).

The DMC1+ parasite ratio was

calculated for the 72 hpi timepoint, along with the z’ score for each replicate. N=56 for
each replicate, 28 each for wells stained with (red) or without (blue) inclusion of antiDMC1 antibody. B) Representative images of HCT8 cells infected with C. parvum and
stained with flourescent conjugated lectin, anti DMC1 antibody and nuclear stain. C)
Combined assay strategy, showing compound addition and imaging timepoints as well
as the four different readouts. Each readout is normalized to the readout value of
vehicle treated wells from the same plate to calculate the “percent inhibition” value. D)
Statistics of the primary screening for all the four readouts, showing average and
standard deviation (SD) of the percent inhibition of vehicle-treated wells and inhibitor
control wells from all the screening plates, as well as all the ReFRAME library
compounds. Note that the expected mean percent inhibition by ReFRAME compounds
with no activity (the vast majority) is 0. Hits were identified as compounds with a
percent inhibition differing from the mean for all compounds by over two standard
deviations.

The cutoff values (library mean ± 2 * Standard deviation) for hit

identification are given in the bottom two rows. E) Heatmap showing the result pattern
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of the primary hits (311 compounds). Compound activity values are z normalized
across each readout using the mean and SD of percent inhibitions for all the compounds
of the ReFRAME library.
Figure 2:

Categories of the validated hits and example dose response

curves. A) Pie chart showing categorization of different hits. 2B to 2L show typical
dose response curves for compounds representative of the different categories. Each
point is from a single biological replicate and each curve shows one of the four
readouts, as indicated in the figure. B) Pan-inhibitor, C) False hit, D) Asexual stage
inhibitors without any activity in the sexual development readout, E) Asexual stage
inhibitors with mid-range efficacy in the sexual development readout, F)
Differentiation inhibitor, G) Differentiation inhibitor with narrow selectivity, H)
Differentiation inducer, I) Development inducer, J) Inducer of both sexual readouts, K)
Compound class undetermined. For 2H and 2J, activity values in the differentiation
readout are excluded for the doses with above 70% asexual inhibition at 72hpi, because
at these concentrations very few parasites were present. L) The dose response curve of
the single compound that induced high DMC1 expression at 48 hours. DMC1+ parasite
ratio at 48 hpi (which is not one of the four standard readouts) is shown in green along
with the four other readouts for this compound only.

Figure 3: Differentiation inhibitors share common putative targets and
they selectively inhibit sexual differentiation across a range of concentrations. A)
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Putative targets of all the categorized differentiation inhibitors. (*) denotes targets in
nucleotide biosynthesis pathways and (**) denotes mitochondrial oxidative
phosphorylation inhibitors. The first nine compounds were selected for follow-up
experiments due to a large concentration window to enable inhibition of sexual
differentiation with minimal effect on parasite asexual growth.

B) Simplified

nucleotide biosynthesis pathway of human cells. Enzyme names are colored and only
enzymes with putative modulators in our validated hits are shown. Inhibitors of (*)
marked enzymes are differentiation inhibitors and others are asexual stage inhibitors.
Red colored enzymes have identified homologs in the C. parvum genome while the
blue colored enzymes do not have an identified homolog in the parasite. PRPP: 5phosphoribosyl

pyrophosphate;

PPAT:

phosphoribosyl

pyrophosphate

amidotransferase; GARTFase: Glycinamide Ribonucleotide Formyltransferase; GAR:
glycinamide ribonucleotide;

IMP:

Inosine monophosphate;

monophosphate;

DHF:

tetrahydrofolate;

DHO: dihydroorotate;

OMP:

Dihydrofolate;

orotidine-5'-monophosphate.

DHFR:
DHOD:

XMP:

Xanthosine

Dihydrofolate reductase;

THF:

dihydroorotate dehydrogenase;

C) Dose response curves of the nine

differentiation inhibitors selected for follow up. Compounds were added at 3 hpi and
imaged at 72 hpi. Partially overlapping concentration ranges were tested for each of
them in 2 to 3 biological replicates. Each point and error bar denotes mean and standard
deviation for readings from 4 separate wells for each concentration in each biological
replicate. The dotted reference line in the Y axis denotes the concentration selected for
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mRNA-seq experiments.

Figure 4:

Differentiation inhibitors are required to be added before

parasite sexual differentiation. A) Experimental setup showing compound addition
timepoints and measured response. B) Dose response curves showing percent inhibition
of the proportion of DMC1+ parasites at 72hpi after the addition of differentiation
inhibitors at indicated timepoints. Each point and error bar denotes mean and standard
error of the mean from 4 replicate well.

Figure 5: Treatment with differentiation inhibitors dysregulates a set of
core genes involved in parasite differentiation. A) Experimental setup for the pilot
mRNA-seq experiment. The number of genes dysregulated (fold change ≥2 at a False
Discovery Rate of ≤ 0.1) between subsequent timepoints of the experiment are listed.
B) Experimental setup and the number of dysregulated genes (fold change ≥2 at a False
Discovery Rate of ≤ 0.1) with differentiation inhibitor treatments. C) Percentage of the
upregulated C. parvum genes in each treatment that is shared by upregulated genes with
other differentiation inhibitor treatments.

D) Percentage of the downregulated C.

parvum genes in each treatment that is shared by upregulated genes with other
differentiation inhibitor treatments.

E) Stage specificity of the genes that are

dysregulated in ≥5 differentiation inhibitor treatments.
Transcriptome data was generated from 2 biological replicates for each
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timepoint and/or treatment, except for 48 hpi control (n=3) and pralatrexate treatment
(n=1).

Figure 6: C. parvum sexual differentiation is associated with suppression of
ribosome formation, which is indicative of a translational repression program. A)
DAVID functional annotation results for significantly dysregulated genes in ≥5
treatments, and between asexual and female C. parvum.

Functional annotation

enrichments with an FDR of ≤0.0001 are included only. Dysregulated genes were
identified at a 10% false discovery rate (FDR) B) Heatmap of the average transcript
per million (TPM) values of ribosomal protein genes of C. parvum at various
timepoints (control) and in treatments with differentiation inhibitors (48 hpi). Each row
represents a single gene encoding a ribosomal protein. TPM values are Z normalized
across each row. Hierarchical clustering between the samples using the expression
values of the ribosomal proteins was performed using the “complete” linkage algorithm
and Euclidean distance metrics and is shown on the top of the heatmap. C) The most
significantly differentially enriched DNA motif in the promoter region of the ribosomal
protein genes compared to all C. parvum genes. D) Chi-square test of the association
between the presence of the DNA motif from (C) in the promoter region of commonly
dysregulated C. parvum genes (excluding ribosomal protein genes) and the direction of
dysregulation. E) The location of the DNA motif from (C) in the promoter region of C.
parvum genes harboring that motif. Other genes include genes that contain the motif in
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their promoter region but are not dysregulated with ≥5 differentiation inhibitor
treatment (fold change ≥1 and FDR ≤ 0.1) and not ribosomal proteins. F) Significant
enrichment (p-value cutoff ≤ 0.5) of the two specific gene ontology (GO) terms during
gene ontology enrichment analysis of apicomplexan genes that are dysregulated
between the listed life cycle stages. Dysregulated genes are defined as genes with a
log2 fold difference of ≥1 at 10% false discovery rate (FDR).

Figure 7:

Promoters of downregulated genes of C. parvum harbor a

recognition site for several ApiAP2 transcription factors that are also
dysregulated by differentiation inhibitor treatments. A) log2 fold change of four
ApiAP2 transcription factors of C. parvum with differentiation inhibitor treatments
when FDR is ≤10%. B) The most significantly differentially enriched DNA motif in the
promoter region of the genes that are ≥2 fold downregulated in ≥5 compound
treatments compared to all C. parvum genes.

Figure 8: A proposed model of repressing C. parvum sexual differentiation
by the two Methionine aminopeptidase 2 (MetAP2) inhibitors.

Eukaryotic

translation initiation factor 2α is abbreviated eIF2α. See the discussion section for
detailed explanation of the model.

Supplementary Table 1: Structure, categorization, and putative mode of action
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of all the compounds selected as hits from the primary screening.

Supplementary Table 2: log2 fold changes of parasite genes between different
treatments and timepoints. Gene names from the Cryptodb database are included along
with the gene IDs. Values are included only if the FDR is below 0.1 in differential
gene expression analysis by DEseq2.

Supplementary Table 3: DAVID functional annotation enrichment analysis of
dysregulated genes (fold change ≥2 and FDR ≤ 0.1) with differentiation inhibitor
treatment.

Supplementary table 4: Eupathdb Gene ontology (GO) enrichment analysis of
various life cycle stages of different apicomplexan parasites. In total, comparisons for 9
different axes of differentiation were performed; 5 from Plasmodium, 2 from Eimeria,
and 1 from Toxoplasma. For each, both upregulated and downregulated genes are
analyzed separately in “cellular component” and “molecular function”, culminating in a
total of 36 comparisons.

Supplementary Figure 1: Dose response curves of all the screening hits. 8point dose response curves of all the primary screening hits in all 4 readouts. IDs
correspond to the compound ids from the first column of Supplementary Table 1.
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Duplicate curves (marked with “#”) are included for compounds that induce sexual
differentiation or development in a dose dependent manner at a concentration range that
is not highly inhibitory to asexual replication. For the duplicate curves, relevant sexual
stage readouts are excluded for high asexual stage inhibitory concentrations.

IDs

marked with asterisks (*) are compounds without a determined dose response in one of
the readouts due to imaging quality error.

Supplementary Figure 2: Volcano plots of dysregulated genes by AGM1470 and Oligomycin A treatment. C. parvum genes are shown with a circle and host
genes are shown with a “plus” sign. Red colored genes are significantly differentially
regulated and blue colored genes are not significantly differentially regulated. P-values
were not calculated for the black colored genes.

Supplementary Figure 3:

C. parvum asexual stage specific genes are

upregulated and female specific genes are downregulated with differentiation
inhibitor treatments. Two Venn diagrams showing the commonality between genes
dysregulated with ≥5 differentiation inhibitor treatments with that of genes
differentially regulated between FAC-sorted asexual and female stage parasites.

Supplementary Figure 4: Stage specificity of genes dysregulated by
differentiation inhibitor treatments. The top panel shows the number of genes in
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each class and the number of genes dysregulated by the treatment from that class. The
bottom panel plots the log2 fold changes of significantly dysregulated (FDR ≤ 0.1)
genes from the corresponding class.
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Figure 1: Stage specific assay development and library screening
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Figure 2: Categories of the validated hits and example dose response curves

145

Figure 3: Differentiation inhibitors share common putative targets and they selectively inhibit
sexual differentiation across a range of concentrations
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Figure 3 (continued)
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Figure 4: Differentiation inhibitors are required to be added before parasite sexual differentiation
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Figure 5: Treatment with differentiation inhibitors dysregulates a set of core genes involved in
parasite differentiation

149

Figure 6: C. parvum sexual differentiation is associated with suppression of ribosome formation,
which is indicative of a translational repression program
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Figure 6 (continued)
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Figure 7: Promoters of downregulated genes of C. parvum harbor a recognition site for several
ApiAP2 transcription factors that are also dysregulated by differentiation inhibitor treatments

Figure 8: A proposed model of repressing C. parvum sexual differentiation by the two Methionine
aminopeptidase 2 (MetAP2) inhibitors
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Supplementary Figure 1: Dose response curves of all the screening hits
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Supplementary Figure 1 (continued)
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Supplementary Figure 1 (continued)
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Supplementary Figure 1 (continued)
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Supplementary Figure 1 (continued)
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Supplementary Figure 1 (continued)
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Supplementary Figure 1 (continued)

159

Supplementary Figure 2: Volcano plots of dysregulated genes by AGM-1470 and Oligomycin A
treatment.

Supplementary Figure 3: C. parvum asexual stage specific genes are upregulated and female
specific genes are downregulated with differentiation inhibitor treatments

160

Supplementary Figure 4: Stage specificity of genes dysregulated by differentiation inhibitor
treatments
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CHAPTER 3: DISCUSSION AND FUTURE DIRECTION
Apicomplexan parasites, other than being huge public health concerns, are
fascinating biological systems to study cell biology, parasitism, and evolution. These
unicellular eukaryotic organisms are obligate intracellular parasites that are capable of
morphing into distinct phenotypic structures throughout their life cycle. Epigenetic,
transcriptional, and translational control of gene expression, undoubtedly shaped by the
condition of the host cell or organism, are the key to achieving this extraordinary feat.
In this study, we have used a chemical genomics approach to study the regulation of
sexual differentiation of the apicomplexan parasite Cryptosporidium parvum. Our data
suggest that (i) this differentiation is expectedly associated with large scale changes in
the parasite transcriptome; (ii) modulating specific pathways of the host affects the
differentiation process; and (iii) global translational control of protein expression likely
mediated by altered ribosomal biogenesis plays a key regulatory role in controlling C.
parvum sexual differentiation, which is perhaps a common mode of regulating stage
differentiation in apicomplexan parasites.

3.1: Potential Function and Stage Specificity of the C. parvum DMC1 protein
We have used the expression of C. parvum DMC1 (Disrupted Meiotic cDNA,
cgd7_1690) protein as a marker for the parasite sexual stage. Most eukaryotes have a
homolog of DMC1 and it is a meiotic recombinase that facilitates homologous
chromosome pairing during meiotic recombination (1). Rad51, which is also a
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recombinase, is a paralog of DMC1 that is also present in most eukaryotes, including
Cryptosporidium. A gene duplication event during early eukaryotic evolution gave rise
to the DMC1 and RAD51 recombinase families (2).

Knocking out DMC1 in S.

cerevisiae arrests its growth at meiotic prophase (3) whereas homozygous DMC1
knockout mice are sterile (4). On the other hand, RAD51 knockout is embryonic lethal
to mice (5).

These and other studies suggest that in most eukaryotes, DMC1

preferentially functions during meiotic recombination whereas RAD51 takes part in
both meiotic and mitotic recombination (1). Previously, using qRT-PCR, we showed
that DMC1 expression peaks at 72 hours post infection (hpi) and correlates with the
emergence of gametocytes in the culture, which was the basis of using DMC1 as a
sexual stage marker (6). Our time-course mRNA-seq experiment also confirms this
observation (Figure 1). Interestingly, RAD51 (cgd5_410) expression also peaks at 72
hpi; however, the level of upregulation from 48 hpi is patently more pronounced for
DMC1.
Immunofluorescence microscopy using an anti-DMC1 monoclonal antibody
identifies DMC1 in uninucleated parasites, strongly suggesting that it is specifically
expressed in female gamonts (6).

This conclusion is further supported by the

observation that immunofluorescence staining of oocysts locates DMC1 within the
oocysts, but outside of the sporozoites (Figure 2). That is because the female gamont
containing parasitophorous vacuoles (PV) ultimately differentiate into oocysts
following fertilization. We also attempted to perform immunoelectron microscopy of
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C. parvum infected HCT8 using our anti-DMC1 antibody clone, but failed to localize
the protein with the method. Perhaps the reason behind this is that the tertiary structure
of the DMC1 protein is sensitive to alcohol treatment. During our initial staining
optimization, we tested different fixatives for the staining and both ethanol and
glutaraldehyde fixation resulted in the loss of anti-DMC1 staining.
Determining parasite stages via alternative methods suggests that the ratio of
macrogamonts in the HCT8 infection model increases logarithmically between 36 and
48 hpi (7, 8), but then the ratio is relatively unchanged between 48 and 72 hpi (7). By
contrast, the DMC1 mRNA level and DMC1+ parasite number increase dramatically
between 48 and 72 hpi (Figure 1 and 2). Our interpretation of these observations is that
the level of DMC1 protein within female gamonts increases to a detectable level as the
gamont matures. Alternatively, it is possible that our specific culture condition delays
the emergence of female gamonts or the other methods overcalculated female gamonts
at 48 hpi. In that case, the low level of staining and the low mRNA level at 48 hpi
compared to 72 hpi might arise from a lower number of female gamonts present at 48
hpi instead of the proposed low level of DMC1 expression by female gamonts. As we
determined the number of DMC1+ parasites at 72 hpi and the ratio of DMC1+ parasites
is consistent with the ratio of female gamonts at that timepoint determined by other
methods, whichever of the above-mentioned explanations is correct does not carry too
much significance regarding our subsequent conclusions. However, the implication of
the first model, that there is a maturation phase of female gamonts that takes around 24
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hours, is in itself an important potential aspect of Cryptosporidium biology that is
worthy of further experimentation. Understanding the requirements and regulations for
the female gamont maturation might give us clues regarding the basis of failed gamont
fertilization in the HCT8 infection model.
Another protein that has recently been used as a macrogamont marker

is

Cryptosporidium oocyst wall protein-1 (COWP1, cgd6_2090) (7). Interestingly, its
expression level is stably maintained after sexual differentiation and does not vary as
dramatically as DMC1 between 48 hpi and 72 hpi (Figure 1). Perhaps the COWP1 is a
marker of female gamont that is independent of its developmental stage, which further
supports our first model of slow maturation of female gamonts.

3.2: The Rationale for Focusing on Differentiation Inhibitors for Follow-up
Experiments
Dose response dependent validation of the screening hits from the ReFRAME
library allowed us to classify compounds into several groups. A major initial goal of
our screen was to determine if differentiation inhibitors could be used to achieve
continuous asexual replication of C. parvum within HCT8 cells, which might allow us
to establish a continuous asexual culture system of Cryptosporidium. Toward that goal,
we assayed C. parvum growth after a prolonged incubation of 7 days post infection in
the presence of the differentiation inhibitors. While the numbers of parasites observed
at these late time points were higher for several treatments compared to control (Figure
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3), we did not observe the maintenance of logarithmic growth that is generally observed
up to 48 hpi.

Our tentative conclusion from this set of experiments is that the

differentiation inhibitors might induce additional rounds of asexual replication;
however, the culture system ultimately becomes unfavorable for continuous parasite
replication. Variation of this experimental setup, like testing other concentrations of
the compounds or adding the compounds multiple times throughout the experiment
might produce a different outcome. The reason we did not pursue this further was that
we also could not successfully subculture parasites from an infected HCT8 monolayer
to an uninfected monolayer, which in our view is an important prerequisite for the
development of a continuous culture system. Instead, we moved forward with utilizing
differentiation inhibitors as tools to examine the genetic regulation of C. parvum sexual
differentiation.

3.3: Potential Follow-up Experiments with Other Compound Classes
The other classes of compounds were theoretically not compatible with our
initial goal of establishing a continuous asexual culture. Therefore, we did not acquire
representative compounds from other classes for follow up experiments. However,
they would be valuable complementary compounds in terms of examining the genetic
regulation of sexual differentiation.

For example, treatment with differentiation

inducers might dysregulate parasite genes in the opposite direction from what we have
observed from the differentiation inhibitor treatments. We are currently in the process
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of performing detailed dose response curves for some of the other compound classes.
After that, we plan to perform mRNA-seq experiments with some of them, analyze the
gene expression dysregulation pattern, and compare that to the dysregulation pattern of
differentiation inhibitor treatments.

3.4: Other Potential Utilities of Differentiation Inhibitors
Recently, several in vitro culture platforms have been described that support the
full C. parvum life cycle (9-13).

Establishment of an air liquid interface (ALI)

condition for mouse intestinal stem cell derived culture produces viable oocysts upon
infection that can further excyst and cause additional rounds of infection (13). The ALI
condition is associated with substantive genetic and metabolic alteration of host cells
compared to non-ALI condition, which led to the suggestion that the host cells under
ALI condition provide a better condition for C. parvum growth. Additionally, small
molecules can be administered in a defined concentration in this culture system (8, 13).
Collectively, this platform is superior to test several potential effects of differentiation
inhibitors on the C. parvum life cycle compared to HCT8 infection model (where the
life cycle is not completed) or in vivo animal infection (where it is challenging to
maintain a specific concentration of compounds in the target tissue).

Our initial

attempts to establish a continuous asexual culture in the HCT8 cells might have failed
because the host cell became inhospitable for supporting prolonged parasite growth.
ALI culture can remove that variable and the effect of differentiation inhibitors would
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be interpreted more clearly.

Also, the druggability of the parasite differentiation

process can be robustly tested with differentiation inhibitors on the ALI culture. If any
of our identified differentiation inhibitors block sexual differentiation in ALI cultures in
a similar way, inhibition of continuous parasite growth would mean that targeting
sexual differentiation would be a viable means for treating cryptosporidiosis. We are
currently in the process of establishing this culture system in our laboratory.

3.5: Potential Genetic Validation of The Chemical Genomics Approach
CRISPR/Cas9 dependent genetic modification of C. parvum was published in
2015, making the parasite genetically tractable (14).

Currently, there is a single

validated selectable marker gene. Therefore, genetic modification of multiple loci is not
possible at this point. Currently available plasmids are not episomally maintained
within the parasite, so transgene expression is only possible by integrating them into the
genome. Thymidine kinase has been proven to be a non-essential gene in the parasite,
and this locus has been used to integrate transgenes (13-15).

Codon optimized

nanoluciferase has been used to detect the transgenic parasites.

Also, several

fluorescent proteins have been successfully expressed and detected in C. parvum.
Genetic knockout and allelic exchange using the CRISPR/Cas9 based strategy
has been successfully demonstrated (14, 16). Importantly, the generation of transgenic
clones requires oocyst formation from transfected sporozoites. Therefore, if a protein is
essential in any of the life cycle stages, there is a high chance that direct knockout of
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the protein or mutations that affect essential functions of the protein would not be
possible. Conditional knockout strategies have yet to be demonstrated for the parasite;
however, a properly working Cre-loxP system has been demonstrated using two
parasite lines, one constitutively expressing Cre recombinase and the another harboring
a floxed site that inhibits expression of a fluorescent gene. Mating of the two lines
allowed expression of the fluorescent protein, demonstrating a functional Cre-loxP
system (7). This system would only be useful for conditional knockout of genes that
are essential between zygote formation to oocyst formation, and can only be studied for
a single generation. Inducible promoters or tunable protein translation strategies have
yet to be established. Conditional knockdown of protein expression strategies would
likely be appropriate for studying the functions of essential genes.

Several such

strategies have been successful in the related Plasmodium and Toxoplasma parasites,
and these approaches have the potential to work with C. parvum also. For example, the
integration of a riboswitch at the UTR of a target gene allows inducible knockdown of
essential Plasmodium genes (17).

Induction of the riboswitch by the exogenous

administration of the ligand glucosamine results in target mRNA degradation.
Several implications from our screening and RNA-seq experiments can be
tested by genetic experiments. Some of them are outlined below:
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3.5.1: eIF2α Phosphorylation Plays a Key Regulatory Role in C. parvum Sexual
Differentiation
Based on the putative mode of action of the methionine aminopeptidase 2
inhibitors, we proposed that phosphorylation of eukaryotic translation initiation factor
alpha (eIF2α) induces parasite sexual differentiation (Chapter 2, Fig 8). Cgd7_5270 is
the annotated eIF2α of C. parvum and sequence alignment with eIF2α from other
organisms suggests serine 57 is the conserved phosphorylation site. Allelic exchange
of the gene to make S57A and S57D mutants, followed by their phenotypic
characterization, specifically their sexual differentiation efficiency, can potentially be
tested with the existing genetic tools.

If making one or both constructs become

challenging (due to being potentially lethal mutation), the WT and mutated genes can
be expressed as a second copy by integrating them in a nonessential locus of the
parasite genome. If possible, the inducible expression of such constructs should be
attempted. The expression pattern of proteins involved in ribosome biogenesis or
structure in eIF2α mutant parasites could potentially elucidate the proposed link
between translational repression and downregulation of ribosome biogenesis.
Knocking out C. parvum MetAP2 (cgd2_2480) followed by testing the sexual
differentiation phenotype would be a good strategy to validate the mode of action of the
MetAP2 inhibitors. The N-terminal lysine-rich domain of the mammalian MetAP2 has
been implicated in the protection of eIF2α from inhibitory phosphorylation (18). A
similar poly-lysine stretch is present in cgd2_2480. Therefore, substituting the native
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locus with an N-terminal truncated version of MetAP2, which might be a more tolerant
genetic modification, could also be used to address the same research question.
3.5.2: ApiAP2 Transcription Factors Regulate C. parvum Sexual Differentiation
The expression of several ApiAP2 transcription factors (TFs) was dysregulated
with multiple differentiation inhibitor treatments. cgd2_2670 is the only ApiAP2 TF
that is highly downregulated with all of the differentiation inhibitor treatments (Chapter
2, Supplementary Table 3). Among others, the putative binding sites of cgd2_3490 and
cgd8_3230 are significantly enriched in the promoter regions of the downregulated
genes. Each of these three TFs would potentially be interesting genetic knockout or
inducible knockdown targets. Also, tagging these proteins with fluorescent proteins or
epitope tags could be useful to validate their expression pattern through the parasite
lifecycle. Alternatively fluorescent proteins could be expressed under the promoters of
these genes. Among the various utilities of epitope tagging, CHIP-seq using anti-tag
antibodies could be used to determine the regulome of these TFs.
3.5.3: C. parum DMC1 is a Female Specific Protein Involved in Meiotic Cell
Division of the Zygotes
Analyzing the expression pattern of DMC1 with high temporal resolution would
help in determining the development kinetics of macrogamonts. This could be done
more comprehensively by live fluorescent imaging compared to staining fixed cells at
different time points. Toward that goal, florescent tagging of the DMC1 protein or
expressing fluorescent proteins under the DMC1 promoter could be attempted. If
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successful, such parasite clones would also be useful in tracking sexual differentiation
in the ALI culture system or animal model infections and serve as a complementary
parasite clone to the already described COWP1-tdTomato parasite clone generated for a
similar purpose (7).

As the DMC1 protein supposedly functions post-fertilization

during sporulation, the Cre-loxP based conditional knockout strategy could be applied
for conditional knockout of DMC1. Complete or conditional knockout of the protein
would help in its functional characterization. Specifically, it would be interesting to
check whether RAD51 can cover for the loss of the DMC1 function.

3.6: Concluding Remarks
The dogmatic view about the Cryptosporidium life cycle is that sexual
differentiation is an obligatory process. Classically, this view has been established
from electron microscopy-based observations of in vivo infection as well as in vitro
infection models where gametocytes emerge after a certain period following infection
(19-21). Recently, life cycle stage typing using alternative methods also showed that in
the HCT8 infection model gametocytes are the predominant parasite population at the
later stage of the infection (6-8). In the ALI culture system, it has been reported that
oocysts are produced in waves that are separated by time intervals when parasites
potentially reset the infection cycle (13). A similar fixed number of asexual replication
cycles has been also proposed for Eimeria, which most commonly undergo three
rounds of asexual replication before sexual differentiation (22). This obligate sexual
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differentiation model is fundamentally different from the two other well studied
Apicomplexa, Plasmodium and Toxoplasma (23). In Plasmodium, a subset of the
asexually replicating parasite population undergoes sexual differentiation, whereas
Toxoplasma sexual differentiation only takes place within the definitive host, cats.
Potential environmental cues for sexual differentiation have also been characterized for
P. falciparum and T. gondii (24, 25). The implication of the defined number of asexual
replication cycles in Cryptosporidium and Eimeria is that a genetic program can sense
the number of asexual replications that the parasite has undergone at any given
moment; however, molecular charecterization of such a sensory mechanism remains
elusive. Alternatively, it is possible that some kind of environmental cue actually
induces the differentiation process in Cryptosporidium and Eimeria, and that
environmental cue reaches a threshold around the time the parasites complete the
defined number of replication cycles. Conceptually, such an environmental cue could
be a parasite generated quorum sensing molecule or depletion/fortification of a host
factor. An in-depth mechanistic understanding of the regulation of C. parvum sexual
differentiation would shed light on this interesting unanswered question about C.
parvum biology.
In this study, we deduced from our RNA-seq analysis that ribosome formation
is downregulated during C. parvum sexual differentiation and coupled this insight with
the putative mode of action of the MetAP2 inhibitors. Another interesting insight that
is supported both by our RNA-seq data and the putative identities of the targets of
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several differentiation inhibitors is that the sexual stage of the parasite is a more
energy-demanding stage compared to the asexual stages. The RNA-seq data supports
this theory as it suggests that glycolysis is upregulated following sexual differentiation,
which is the most critical energy producing pathway for the parasite in the absence of a
fully functional mitochondrion. It is proposed from other studies that Cryptosporidium
uptake energy equivalents from the host cells directly in the form of purine nucleotides.
Therefore, our theory of increased energy demand in the sexual stage is also supported
by the observation that inhibitiors of host cell oxidative phosphorylation and purine
nucleoide biosynthesis, two pathways involved in producing the energy molecules that
Cryptosporidium can steal from the host, also disproportionaltely affect the sexual
stages of the parasite more.

Targeted genetic experiments are needed to test the

validity of this hypothesis.
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Figure 1: Expression time course of selected genes.

Transcript per million (TPM) values of DMC1, RAD51 and COWP1 mRNAs at
different time-points post infection. Each point represents a biological replicate of
mRNA-seq. Error bars denote range.
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Figure 2: C. parvum oocysts stained with anti DMC1 antibody.

DMC1 protein is localized to the inner wall of C. parvum oocysts and is stained only
when the oocysts are exysted.
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Figure 3: Parasite numbers after 7 days post infection with differentiation inhibitor treatments.

(Top) Dose response curves of total parasite and DMC1+ parasite percent inhibition
compared to control, determined from drug addition at 3 hpi and imaging at 72 hpi.
Concentrations selected for prolonged (7 days) assays are indicated by the dotted
vertical lines.

(Bottom) Three differentiation inhibitors were added to C. parvum

infected HCT8 culture at 3 hours post infection at indicated concentrations. Wells were
fixed and imaged at 7 days post infection. Vicia villosa lectin (VVL) was used to count
parasite number and Hoechst staining was used to count host cell nuclei number. Each
point indicates data from replicate wells.
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